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GENERAL INTRODUCTION
Physical activity and diet are among the most commonly advocated lifestyle measures to 
improve skeletal health1. With respect to physical activity, Julius Wolff and Wilhelm Roux at 
the end of the nineteenth century already observed that bone mass and structure change 
under influence of the mechanical load that bone carries. While Julius Wolff focused on the 
mathematical rules predicting bone shape, Wilhelm Roux proposed a concept of functional 
adaptation as a self-organized process based in the tissues2.
While increased mechanical loading (e.g. due to exercise) results in a higher bone mass, 
unloading (e.g. due to bed rest) results in a decrease in bone mass. It is currently believed 
that mechanotransduction, the process by which a mechanical signal is transduced into a 
chemical signal by cells in bone that sense mechanical loading, proceeds as follows. When 
bones are loaded, the resulting matrix strains force the interstitial fluid that surrounds the 
osteocytes to flow over the osteocyte processes, which are positioned in the canaliculae3,4. 
Osteocytes sense and translate this fluid flow into a chemical signal that alters the bone 
remodeling activities of osteoblasts and osteoclasts5,6. Among the most widely studied 
signaling molecules produced by osteocytes in response to mechanical stimulation are nitric 
oxide (NO) and prostaglandin E
2 
(PGE
2
). 
PGE
2
 is abundantly expressed and active in bone and is generated in cells by PGE-
synthase from prostaglandin H
2
7. The rate-limiting enzyme in prostaglanding H
2 
synthase is 
cyclooxygenase (COX). Although several PGE-synthases have been identified, prostaglandin 
E synthase-1 is known as the key enzyme in the formation of PGE
2
. PGE
2
 regulates bone 
resorption by affecting osteoclast activity as well as bone formation by inducing osteoblast 
proliferation8 and differentiation9. In vitro, PGE
2
 production primarily leads to bone 
resorption. In contrast, PGE
2
 stimulates both bone formation and resorption in vivo10. 
NO is a short-lived, highly reactive free radical involved in many biological processes, 
including the regulation of bone metabolism11. NO inhibits osteoclast activity12, and mediates 
the anabolic response of bone to mechanical loading in vivo13. The loading-induced NO 
production in osteocytes results from the activity of endothelial cell nitric oxide synthase 
(ecNOS)14. In cell culture experiments, osteocytes produce high levels of NO in response to 
mechanical loading in the form of fluid shear stress14-16. 
Bone morphogenic proteins (BMPs) are produced in response to mechanical loading, 
and BMPs might have a relevant role in bone mechanotransduction. BMP gene expression is 
upregulated after mechanical loading in chondrocytes17, rat achilles tendon18, and vascular 
endothelial cells19. Moreover the BMP antagonist noggin inhibits mechanical loading-
induced chondrocyte proliferation17. Production of molecules involved in bone remodeling 
such as BMPs, NO, and PGE
2
 by bone cells is affected by mechanical stimuli, but may be also 
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affected by nutrition. This could, at least partially, explain how nutrition contributes to a 
lower risk for bone-related diseases20.
A striking example of how nutrition affects bone health is provided by the lower incidence 
of osteoporosis in Mediterranean countries21,22. An environmental factor determining this 
lower risk is the Mediterranean diet, which includes a high intake of olives and olive oil. 
Soybean isoflavones, an important dietary component of the Asian diet, are currently 
thought of as a potential alternative therapy for osteoporosis as well. There is convincing 
evidence for the potential role of the soybean isoflavone genistein in the prevention of 
osteoporosis and reduction of fraction risk from human studies23 and animal studies24,25. 
Together the findings described above indicate that a balanced diet and an active life style 
can be beneficial to improve bone health. Whether nutrition and mechanical loading are 
able to interact in their effect on bone turnover and thereby  synergistically affect bone 
mass maintenance and accrual is currently unknown, and therefore the major question 
addressed in this thesis.
This thesis focuses on the effect of nutrients on the response of mechanosensitive bone 
cells to mechanical stimuli. The overall aim was to identify nutritional factors that alter the 
bone cell response to mechanical loading. We also assessed whether the combination of 
certain nutrients and mechanical stimuli can counteract the effects of inflammatory cytokines 
on mechanosensitive bone cells, since bone loss after the menopause and generalized 
bone loss associated with systemic inflammatory diseases may be partially attributed to an 
increase in cytokines in the circulation (for a review see Geusens and Lems, 2011)26. 
In this thesis the following scientific questions were addressed:
1.  What are the pathways leading to the release of signaling molecules, specifically bone 
morphogenetic proteins, by bone cells in response to mechanical loading?
2.  How do dietary components that are used as agents in osteoporosis treatment, such as 
1,25-dihydroxyvitamin D
3
 and fluoride, affect the response of osteocytes to mechanical 
stimulation? 
3.  Could nutrients such as oleuropein potentially counteract inflammation-induced 
bone loss by restoring the altered response of bone cells to mechanical stimuli in an 
environment of inflammation?
In chapter 2, the effect of mechanical loading on the production of bone morphogenetic 
protein 2 and 7 by human bone cells was investigated. In chapter 3 we tested the effect 
of fluoride on the response of bone cells to mechanical loading. Another metabolic bone 
agent present in the diet is 1,25(OH)
2
D
3
. In chapter 4 we assessed whether 1,25(OH)
2
D
3 
affects NO production via the vitamin D receptor (VDR), in the presence and absence of a 
mechanical stimulus. In chapter 5 we investigated whether oleuropein alters the effect of 
the cytokine interleukin-1b on the osteocyte response to mechanical stimulation. Nutrients 
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also have an effect on gut hormones, which in turn can affect bone mass. In chapter 6 we 
explored the effect of the gut hormone glucose dependent inhibitory peptide (GIP) on the 
response of bone cells to mechanical stimulation. Finally, in chapter 7, we discuss how our 
results provide new insights in the molecular pathways that are activated in osteocytes 
subjected to mechanical loading, and how nutrients affect this process. These insights could 
contribute to the development of products, i.e. a personalized exercise and diet programme, 
to maintain existing bone mass and aid the gain of new bone mass in people that are likely 
to develop osteoporosis.   
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ABSTRACT
Considering our ageing population and the expected concomitant increase incidence of bone 
loss-associated fractures, it is of the utmost importance to develop novel therapies that 
enhance bone strength in a safe and efficient way. Dietary intake of dairy products positively 
affects bone mineral density in early life, and reduces loss of bone mass with ageing. In 
addition, regular weight-bearing physical activity has a strong positive effect on bone. This 
review focuses on the possible synergistic effects of nutrients and mechanical stimuli for 
bone health. Bones contain a vast number of interconnected living cells embedded within 
the calcified extracellular matrix. These cells, the osteocytes, perceive the mechanical 
stimuli evoked during weight-bearing exercise. In response to mechanical stimuli, osteocytes 
produce potent signaling molecules that affect the formation and activity of bone forming 
osteoblasts and bone resorbing osteoclasts. As a consequence, any factor that alters the 
response of osteocytes to mechanical stimuli, potentially affects bone mass and structure. 
We identify a number of nutrients, which are expected to enhance the beneficial effect of 
physical activity on bone mineral density by enhancing osteocyte mechanosensitivity. Such 
nutrients may have a synergistic effect on bone health when combined with a regime of 
physical activity, providing an efficient and safe way to combat fractures in the elderly. 
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INTRODUCTION
Skeletal diseases such as osteoporosis increase the risk of bone fracture1. Since osteoporosis 
is primarily a disease of the elderly, the concern is growing that with the increased aging 
of the human population, the incidence of osteoporosis-related fractures will substantially 
rise over the coming decades2. In 2000 the costs of osteoporotic fractures in Europe alone 
have been estimated at €31.7 billion, and these costs are expected to increase up to €76.7 
billion in 20503. More importantly osteoporosis-related fractures often lead to a diminished 
quality of life, disability, discomfort, and even death. Thus prevention of these fractures is 
required4. 
Daily physical activity and a healthy diet are among the most commonly advocated 
lifestyle measures to improve (skeletal) health5. The European Food Safety Authority (EFSA) 
states the importance of a balanced nutrition for healthy bones. Vitamin D and calcium are 
well known for decades for their contribution to bone health6. Recently other nutrients like 
magnesium, vitamin K, and carotenoids, have been shown to positively affect bone health 
as well7. It has been proven that bone health benefits from a balanced diet consisting of 
fruit, vegetables, adequate dairy and other protein-rich food intake, and a limited intake of 
low nutrient-density food7.
Regarding the contribution of daily mechanical loading to bone health, Roux (1850-1924) 
proposed a concept in which daily mechanical loading of bone leads to the adaptation of 
bone structure to optimize the load-bearing capacity of bone8. How much physical activity 
exactly contributes to bone mass is difficult to predict, but a lack of physical activity, e.g. 
as is seen in bed-ridden patients, quite obviously results in a rapid and substantial loss of 
bone mass9. Moreover compelling evidence exists showing that high impact physical activity 
in adults has an anabolic effect on bone mineral content (BMC) and bone mineral density 
(BMD)10. The BMC and BMD and have been shown to increase up to 20% in the loaded bone 
regions in athletes11-15. 
Bone mass at the age of 70 largely depends on peak bone mass reached before the 
age of 3021. High impact physical activity in childhood, especially when initiated before 
puberty, results in increased bone width and increased bone mineral content in girls and 
adolescent females22. Therefore a physical activity regime that has started before puberty 
may be used for the prevention of osteoporosis and fractures at a later age23. During growth, 
not only high impact activity but also low impact activity contributes to skeletal health16-18. 
High magnitude mechanical loads as well as loads applied at high frequency are known to 
increase bone mass, but low impact activities have less effect on bone even when applied 
for a long duration19,20. It is much debated whether the efficiency of physical stimuli for 
increasing bone strength diminishes with age, especially after the menopause. Exercise may 
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benefit bone health in adults since bone resorption and bone turnover markers are reduced 
by one month of moderate intensity exercise, i.e. 3 times per week and 30 minutes per 
day, in both pre- and postmenopausal woman24. Important bone health biomarkers are also 
favorably affected by a high intake of dairy, calcium, and protein during diet- and exercise-
induced weight loss in premenopausal overweight and obese women25, indicating that both 
exercise and diet contribute to the maintenance of bone health.
It seems reasonable to expect that a combination of dietary components and physical 
activity will efficiently lead to stronger and thicker bones. However, it is still largely unknown 
which nutrients actually enhance the gain in bone mass achieved with moderate daily 
physical activity. Therefore we aimed to identify nutrients with the potential to enhance the 
effect of physical activity on bone mass. We focus on osteocytes, the bone cells responsible 
for the adaptive response of bone to mechanical signals.
 
THE ROLE OF OSTEOCYTES IN BONE HEALTH 
The idea that bone is a dead tissue could not be further from the truth. Bone is made up of 
a combination of organic and anorganic matrix, and contains four types of living cells, i.e. 
osteoblasts, osteoclasts, osteocytes, and bone lining cells. Osteoblasts are bone forming 
cells that produce collagens and proteins that play a role in the initiation of bone matrix 
calcification26. Osteoclasts degrade bone by matrix demineralization and degradation of 
collagen and non-collagenous proteins. The osteoclasts and osteoblasts act in concert to 
continuously repair micro-damage caused by fatigue loading, through targeted remodeling27. 
This process is believed to be orchestrated by the osteocytes28. The process of bone 
remodeling (Figure 1) facilitates the adaptation of bones to their mechanical environment29. 
During bone remodeling excess bone is removed in regions exposed to low loads and new 
bone is deposited in regions exposed to high loads. Osteocytes are the mechanosensor 
cells in bone. During bone formation, a subpopulation of osteoblasts undergoes terminal 
differentiation and become embedded within the bone as osteocytes30,31. The osteocytes 
constitute 95% of all cells in bone and form a network of numerous cell extensions 
(“fingers”) extending throughout the mineralized bone, which enables cell-cell contact32. 
The cell “fingers” lie within the canaliculi in the calcified bone matrix and are surrounded by 
a thin layer of interstitial fluid33. 
It has been subject to much debate how a mechanical signal in intact bone is transduced 
into a signal that activates the osteocytes34. The deformations in healthy bones as a result of 
normal daily activity are quite small35. Deformation in animal and human long bones never 
exceed 2000-3000 microstrain (a 0.2-0.3% change in length when compared to the original 
length of the bone)19, and on a daily basis deformations of this order of magnitude are 
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rare. It is uncertain whether bone cells can directly perceive those small daily deformations, 
even though it is certain that such stimuli maintain bone mass. Thus a biological system 
must exist that somehow amplifies the mechanical signals. According to the canalicular 
flow hypothesis, mechanical stimuli deform the bone tissue, causing the interstitial fluid to 
flow through the lacuno-canalicular network over the cell “fingers”32. This can be compared 
with squeezing a stiff, water-soaked sponge. The osteocytes sense this fluid flow and start 
producing signaling molecules such as nitric oxide (NO) to alter the activity of osteoblasts 
and/or osteoclasts. NO is produced by the enzyme nitric oxide synthase (NOS), and NO 
production is a well known and essential early response of osteocytes to mechanical loading 
in vivo36. Thus NO can be measured to get an impression of the magnitude of the biological 
response of osteocytes to mechanical loading. The mechanical signal can be mimicked in 
vitro by means of a laminar fluid flow exerted on a monolayer of cultured osteocytes or 
osteocyte-like cells. Osteocytes are often subjected to a pulsatile fluid flow (PFF) in vitro37. 
Within minutes after PFF application, the osteocytes start to release NO and prostaglandin 
E
2
 (PGE
2
)38,39. PGE
2
 production is mediated by the enzyme cyclooxygenase (COX)40. There are 
several isoforms of COX, of which COX-2 is the isoform that is induced by mechanical loading 
in vitro41 and in vivo42. 
Figure 1. The adaptation of bone to the ever changing mechanical demands takes place during the 
complicated bone remodeling process. Bone remodeling involves four main processes, i.e. activation, 
resorption, reversal, and formation. The remodeling cycle is initiated by osteocyte apoptosis and 
activation of bone lining cells. Osteoclast precursor cells are recruited to the activated surface and 
fuse to form mature, bone resorbing osteoclasts, where they attach and start to dissolve bone 
matrix, creating a resorption pit. When bone resorption eventually subsides, osteoclasts disappear 
and mononuclear cells arrive that differentiate into osteoblasts. The remodeling cycle ends with the 
synthesis and deposition of bone matrix by osteoblasts. The newly formed bone will then be covered 
by bone lining cells, until the next cycle.
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THE ROLE OF NUTRIENTS IN THE DETERMINATION OF OSTEOCYTE SHAPE
Lately the view of the cytoskeleton as a structure responsive to external physical and chemical 
stimuli has become more prominent43. The cytoskeleton is involved in mechanosensing 
and is a key determinant of the material properties of the cell. The effects of microstrain 
(με) stresses on a cell largely depend on the material properties of that cell. In bone, 
low magnitude (<10 με) and high frequency (10–100 Hz) loading stimulates bone mass 
and strength in vivo44. For bone cells it has been shown that the production of signaling 
molecules in response to fluid shear stress and vibration stress in vitro is correlated with the 
applied stress rate45. The faster the stress was applied, the stronger the observed response 
of the cells. Moreover, osteocytes with round suspended morphology require lower force 
stimulation in order to show an increase in NO production, while they are an order-of-
magnitude more elastic compared to flat adherent cells43. Apparently, round osteocytes 
seem to require less mechanical forces in order to respond than stiffer cells. These findings 
indicate that differences in mechanosensitivity in osteocytes are related to the shape 
and material properties of the cell43. The shape of cytoskeletal structures depends on the 
dynamics of actin fibers and microtubules46,47. Actin fibers are most abundant in eukaryotic 
cells and form a framework that supports and shapes the plasma membrane. Microtubules 
exhibit structural and functional polarity and are important components of primary cilia48, a 
mechano-sensitive structure that is likely also present on osteocytes49. 
The question arises whether it is possible that nutrients affect the cytoskeleton of bone 
cells, thereby affecting their mechanosensitivity. Fluoride is known to disrupt the actin 
cytoskeleton of protozoa50 and actin fibers in ameloblasts51, leading to a disrupted actin-
cytokeleton and thus more rounded cells. Therefore fluoride might enhance osteocyte 
mechanosensitivity. The polyphenol oleuropein disrupts microtubules in tumor cells, also 
resulting in rounded cells and altered cytoskeletal organization52. Genistein, an isoflavone, 
mostly present in soybeans, depolymerizes the microtubules in human A549 epithelium 
cancer cells, and inhibits microtubule polymerization in vitro53. These findings suggest a role 
for fluoride, oleuropein, and genistein in the mechanoresponse of osteocytes.
THE ROLE OF (PHYTO-) ESTROGEN IN BONE CELL MECHANOSENSITIVITY
Estrogen is known to have profound anabolic effects on bone. Decreased estrogen levels 
following menopause have a strong negative effect on bone mass54. On the other hand, 
administration of exogenous estrogen increases bone mineral density in humans55,56, and 
high estrogen concentrations induce new bone formation in mice57,58. These effects of 
estrogen on bone can be explained by its opposite effects on osteoclasts and osteoblasts. 
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Estrogen can suppress bone resorption and stimulate bone formation after binding to its 
receptor present on both osteoclasts and osteoblasts54,59. In addition, estrogen likely alters 
the response of osteocytes to mechanical loading via modulation of the estrogen receptor 
α60, thereby affecting bone mass. It has been suggested that osteocytes become less 
sensitive to mechanical stimuli in woman after menopause, due to the estrogen loss. This 
would explain the rapid loss in bone mass associated with menopause61. Phytoestrogens are 
plant-derived compounds with estrogen-like activity, and therefore it is possible that these 
agents affect osteocyte mechanosensitivity. Daidzein and genistein are two examples of 
phytoestrogens derived from soy-beans. Genistein stimulates bone-nodule formation and 
the release of osteocalcin via the estrogen receptor-dependent pathway in rat osteoblasts 
in vitro 62, suggesting that genistein potentially affects osteocyte mechanosensitivity. 
Like genistein, daidzein stimulates bone-nodule formation and osteocalcin release in rat 
osteoblasts in vitro, but this effect is likely not mediated by the estrogen receptor62.
NUTRIENTS AFFECTING THE DIFFERENTIATION OF OSTEOBLASTS INTO 
OSTEOCYTES
Osteocytes are derived from osteoblasts. Osteocytes are highly mechanosensitive, 
but osteoblasts and osteoblastic cell lines also show mechanosensitivity63. Osteoblasts 
differentiate into osteocytes, and as a result become more sensitive to mechanical loading63. 
Nutritional components that are able to stimulate osteoblast differentiation might therefore 
enhance the mechanoresponse, which ultimately will lead to adaptive changes in bone 
mass.
The component fluoride is well known for its effect on osteoblast differentiation. It 
increases osteoblast proliferation and differentiation in a rat osteosarcoma cell line64. 
Osteoblast mitochondrial activity is also stimulated by fluoride, which also leads to 
osteoblast differentation65. Lactoferrin, a pleiotropic factor, stimulates both osteoblast 
proliferation and differentiation66. Lactoferrin potently increases differentiation of 
osteoblasts into osteocytes67. Since both genistein and daidzein seem to stimulate osteoblast 
differentiation68, it is possible that they affect the mechanoresponse of osteoblasts as well. 
Other components that are known to enhance osteoblast differentiation are strontium, 
isoflavones, and whey protein69-71.
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NUTRIENTS AFFECTING THE PRODUCTION OF SIGNALING MOLECULES
NO and prostaglandins are early parameters for bone formation and essential for the anabolic 
response of bone to mechanical loading in vivo72. NO is a short-lived molecule involved in the 
regulation of bone metabolism73, and is formed by the conversion of L-arginine in L-citrulline 
by NOS74. PFF-induced NO production by bone cells results from the activity of endothelial 
NOS75. NO is known to inhibit osteoclast activity76. Both animal studies and pilot studies in 
humans support the use of NO donors to prevent bone loss77. Since NO is formed during the 
conversion of L-arginine by NOS, it is feasible that the amino acid arginine plays a role in the 
process of adaptive bone formation. Several studies have shown that arginine administration 
significantly increased alkaline phosphatase, NO, and insulin like growth factor-I production, 
as well as type I collagen synthesis by human osteoblasts, and in osteoblasts derived from 
calvaria of newborn rats78.
Prostaglandins are generated by the release of arachidonic acid from phospholipids 
in the cell membrane, followed by conversion of arachidonic acid into prostaglandin G2 
and subsequently prostaglandin H
2
 by COX79. Prostaglandin H
2
 is further isomerised to the 
biological active prostanoids, such as PGE
2
79. COX-2, but not COX-1 is likely essential for the 
anabolic effect of mechanical loading in bone40. Any nutrient that affects COX-2 activity thereby 
potentially affects the anabolic response of bone to mechanical loading. PGE
2 
(10-8 M) affects 
bone formation by inducing osteoblast proliferation and differentiation80-82. Higher PGE
2 
concentrations (10-7 M) stimulate bone resorption in vivo and osteoclastogenesis in vitro83. 
Moreover PGE
2
 and COX-2 at high concentrations play an important role in inflammatory 
processes, often associated with trabecular bone loss, and leading to osteoporosis. The role 
of arachidonic acid and phospholipids in this important regulatory pathway suggest that fatty 
acids in the diet may influence the process of mechanical adaptation of bone. Especially the 
dietary ratio of omega 6 to omega 3 fatty acids is important, i.e. lowering this ratio seems 
to diminish PPAR-γ activation and thereby promotes osteoblastogenesis at the expense of 
bone marrow adiposity. Only few studies have been conducted addressing the prevention 
or treatment of osteoporosis by dietary poly-unsaturated fatty acids84,85. Epidemiological 
evidence indicates that diets containing omega 3 fatty acids are beneficial to skeletal health. 
A recent review concludes that any potential benefit of omega 3 fatty acids on skeletal 
health may be enhanced by concurrent administration of calcium85. However whether fatty 
acids, either or not in combination with calcium, modulate osteocyte mechanosensitivity is 
unknown.
Osteoporosis-related fractures are lowest in Southern Europe, which is likely related to 
dietary influences86. Olive oil and its main compound oleuropein are abundantly present in 
the Mediterranean diet. Oleuropein at 10-100 µg/ml reduces the levels of COX-2 seen in 
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inflammation87. Lower concentrations of oleuropein (10-4-10-6 M) increase NO production 
via induction of inducible NOS by macrophages in a mouse infection model, thus increasing 
functional activity of these cells88. Another polyphenolic compound, chlorogenic acid (CGA), 
decreases the inflammation-induced production of PGE
2
 as well as the expression of COX-2 
in RAW 264.7 macrophages89, implementing a role for polyphenols in inflammation-induced 
bone resorption. Strontium is known for its effect on the proliferation of pre-osteoblasts, and 
the stimulation of bone formation90. In both MC3T3-E1 osteoblasts and PC-3 cells, strontium 
indirectly induces the production of PGE
2
 via IL-691. Together these findings suggest a role 
for strontium in bone turnover. The components discussed above are known to affect PGE
2
, 
COX-2, and NO production, and therefore they are likely to increase the response of bone 
cells to mechanical stimulation.
Bone remodeling strongly depends on the communication between osteocytes and 
osteoblasts and osteoclasts. Osteoclasts are formed by the fusion of mononuclear osteoclast 
precursor cells92 and express tartrate-resistant acid phosphatase, an osteoclast marker. RANKL 
is a membrane-bound cytokine and binds to its receptor RANK on osteoclast precursors93. 
Binding of osteoprotegerin (OPG) to RANKL results in suppression of osteoclast formation 
in vivo and in vitro94. The ratio OPG/RANKL is therefore considered crucial in osteoclast 
formation95. RANKL is also expressed by osteocytes in bone microdamage96, and apoptotic 
osteocytes directly and indirectly initiate bone resorption by recruitment of osteoclast 
precursor cells to the local damage site97. Vitamin K is present as phylloquinone (vitamin K1) 
and menaquinones (vitamin K2), e.g. MK-7, MK-8, and MK-998. Vitamin K2 inhibits osteoclast 
formation by decreasing RANKL99. It also inhibits PGE
2
-stimulated osteoclast formation100. 
Incubation of human monocytes with RANKL and M-CSF leads to inhibition of osteoclast 
formation. MK-7 suppresses proliferation, but enhances OPG, RANKL, and RANK gene and 
protein expression in MC3T3-E1 osteoblasts101. Recent data show that osteocytes express 
much more RANKL and have a greater capacity to support osteoclastogenesis in vitro than 
osteoblasts or bone marrow stromal cells102. The severe osteopetrotic phenotype observed 
in adult mice specifically lacking osteocyte-derived RANKL indicates that osteocytes are the 
major source of RANKL during bone remodeling in vivo thereby determining bone mass102. 
Expression of the PTH receptor is not limited to a specific tissue, and both osteoblasts 
and osteocytes but not osteoclasts have been shown to express PTH receptors103. PTH is 
secreted by the parathyroid glands during bone resorption to maintain serum calcium 
levels. PTH binds to and activates the PTH receptor on osteoblasts in bone104. It activates 
protein kinase A and protein kinase C together with intracellular signaling pathways leading 
to osteoclast recruitment105. This recruitment of osteoclasts to the remodeling site is a signal 
for the osteoblasts to deposit bone matrix, and is generated by osteocytes via PTH. Oral 
administration of glucose rapidly decreases serum levels of PTH106. 
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The role of 1,25-dihydroxyvitamin D
3
 in bone mineral homeostasis is to promote intestinal 
absorption of calcium and phosphate107. 1,25-Dihydroxyvitamin D
3 
masters calcium and 
phosphate homeostasis through cross-regulation of PTH, but also via osteoclastogenesis 
and osteoblastogenesis, calcium and phosphate acquisition, and regulation of anabolic and 
catabolic gene expression, in order to achieve a proper mineral and skeletal metabolism108. 
Vitamin D deficiency results in inadequate intestinal calcium absorption and increased 
PTH levels, which possibly leads to accelerated bone loss109. Daily supplementation of 
postmenopausal women with 400 IU vitamin D per day reduces PTH levels and increases 
bone mineral density at the femoral neck110,111. It has been shown that PTH reduces the 
mechanical stress-induced NO production112. Since glucose and vitamin D decrease serum 
levels of PTH106, 111, these nutrients might positively affect the mechanical loading-induced 
NO production. 
THE COMBINED EFFECT OF NUTRITION AND MECHANICAL LOADING ON 
BONE IN VIVO
Cortical bone contains osteons, which are composed of a central Haversian canal surrounded 
by bone matrix. The Haversian canal encompasses blood vessels and nerves throughout the 
bone and communicates with osteocytes in lacunae through canaliculi113. After ingestion, 
nutrients enter the blood stream and are delivered to the bone, where the reach the bone 
cells. A balanced diet and other nutrients in combination with an active life style can thus be 
beneficial to improve bone health by affecting osteocytes114. 
The major drawbacks of studies on bone in vivo are the associated high costs and the 
long-term duration of the experiments. Therefore only few studies have been conducted on 
the effect of a combination of physical activity and a balanced diet on bone health under 
normal daily circumstances. Bone mass status in athletes is definitely determined by a 
combination of systemic hormones, nutrition, and exercise. The total body mineral density/
bone mineral content ratio of the calcified matrix is relatively high in female dancers, 
which is caused by high levels of physical activity and a balanced diet115. Physical activity 
and a high-fat diet results in increased trabecular bone mineral density and improved 
three-dimensional (3D) micro-structure in obese mice116. Low calcium intake diminishes 
the increased bone mass resulting from exercise in prepubertal girls117. Limited evidence 
exists regarding a relationship between vitamin D intake and fracture prevention by physical 
activity118. One of the few studies conducted on the effect of diet and physical activity in 
healthy subjects (age 14-18 yrs) shows that the main dietary variables related to bone mass 
are energy intake, calcium, vitamin D, and servings of dairy products, in combination with 
vigorous (jumping) physical activity119. The in vivo experiments described above suggest 
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that nutrients and physical exercise have at least an additive effect on bone health. Further 
studies should reveal whether nutrients and physical exercise synergistically enhance bone 
health in humans in vivo. The consumption of vitamin-enriched dairy products might be of 
great benefit when the natural intake is not sufficient, e.g. in older people (age >50 yrs) or 
professional athletes.
CONCLUDING REMARKS
The increasing number of patients suffering from osteoporosis is accompanied by high 
costs and decreased quality of life, and therefore new therapeutic approaches are urgently 
needed. Most approaches focus on the prevention of osteoporosis. Given the crucial 
importance of nutrients and physical activity for bone health in general, we suggest a new 
approach existing of a ‘change in lifestyle’, i.e. a regime of daily exercise and a balanced diet, 
possibly fortified with bone formation-stimulating nutrients. A better understanding of the 
pathways involved in the process of mechano-transduction and the regulating factors in 
daily nutrition is necessary to develop a life style advise. In this review several mechanisms 
have been identified by which nutrients could modulate the beneficial effect of mechanical 
stimuli on bone health. The establishment of the effects of nutrients on mechanical loading-
induced bone formation in vivo needs further investigation. This review also identifies a 
number of nutrients, i.e. fluoride, oleuropein, (phyto)estrogens, lactoferrin, strontium, 
vitamin K, vitamin D, and glucose, with great potential for enhancing bone health when 
applied in combination with mechanical stimuli. It is to be expected that this list can be 
expanded in the future as research progresses, holding great promise for finding a balanced 
therapeutic approach for the prevention of age-related bone loss.
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ABSTRACT
Bone mechanical adaptation is a cellular process that allows bones to adapt their mass and 
structure to mechanical loading. This process is governed by the osteocytes, which in response 
to mechanical loading produce signaling molecules that affect osteoblasts and osteoclasts. 
Bone morphogenic proteins (BMPs) are excellent candidates as signaling molecules, but it is 
unknown whether mechanically stimulated osteocytes affect bone adaptation through BMP 
production. Therefore, the aim of this study was to assess whether osteocytes produce BMPs 
in response to mechanical loading. In addition, since BMP7 has a vitamin D receptor (VDR) 
response element in the promoter region, we also investigated whether VDR is involved 
in the BMP7 response to mechanical loading. Human or VDR−/− mouse primary bone cells 
were submitted in vitro to 1 h pulsating fluid flow (PFF) and postincubated without PFF 
(PI) for 1–24 h, and gene and protein expression of BMP2 and BMP7 were quantified. In 
human bone cells, PFF did not change BMP2 gene expression, but it upregulated BMP7 
gene expression by 4.4- to 5.6-fold at 1–3 h PI and stimulated BMP7 protein expression by 
2.4-fold at 6 h PI. PFF did not stimulate BMP7 gene expression in VDR−/− mouse bone cells. 
These results show for the first time that mechanical loading upregulates BMP7, likely via 
the VDR, but not BMP2, gene and protein expression in osteocytes in vitro. Since BMP7 
plays a major role in bone development and remodeling, these data might contribute to a 
better understanding of the mechanism leading to the mechanical adaptation of bone. 
Keywords Bone adaptation; Bone morphogenic protein 2; Bone morphogenic protein 7; 
Osteocyte; Mechanical loading. 
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INTRODUCTION
Mechanical adaptation of bone is a cellular process that allows bones to adapt their mass 
and structure to their mechanical environment1,2. It is currently believed that this process 
of adaptation is governed by the osteocytes3-6. Osteocytes are terminally differentiated 
osteoblasts that become embedded deep within the mineralized bone matrix during bone 
formation. They are regularly distributed throughout the bone matrix and connected to 
each other by cytoplasmatic protrusions that run through the canaliculi7. This way the 
osteocytes form a unique dendritic network that enables contact not only with the bone 
surface but also with other cells7. When bones are loaded, the resulting deformation causes 
a flow of interstitial fluid through the lacunocanalicular network8,9. This flow of fluid results 
in mechanical stimulation of the osteocytes6,8,9. The mechanically stimulated osteocytes 
then produce signaling molecules that are potent regulators of the other types of bone cells, 
i.e., osteoblasts and osteoclasts, during bone remodeling10,11. A multitude of interacting 
signaling pathways are involved in translating the load applied on bone into the production 
of signaling molecules by osteocytes12. 
Bone morphogenic proteins (BMPs) are excellent candidates as signaling molecules that 
could be produced in response to mechanical loading. BMPs belong to a family of genetically 
conserved secreted signaling molecules of the transforming growth factor-β superfamily 
of polypeptides (for review, see Chen et al.13)14. BMPs signal through heteromeric type I 
and type II serine-threonine receptors and activate the intracellular signalling molecules 
Smad1, Smad5, and Smad8 through serine phosphorylation13. Activated Smad proteins form 
heterodimers with the co-smad, Smad 4, and translocate to the nucleus to mediate the 
transcription of BMP-dependent target genes13. 
BMPs might have a relevant role in bone mechanotransduction. BMP2/4 is upregulated 
by mechanical loading through the induction of Indian hedgehog in chondrocytes, and the 
BMP antagonist noggin inhibits mechanical loading-induced chondrocyte proliferation15. 
This indicates that BMPs are part of the transduction pathway that is activated in response 
to mechanical loading in chondrocytes15. Mechanical loading of the rat achilles tendon 
upregulates BMP7 gene expression16. It upregulates BMP2 gene expression in endothelial 
cells of the vascular system17. This suggests that BMPs might be part of the signaling 
pathways that are activated upon mechanical stimulation. Remarkably, the data available 
on the role of BMPs in bone mechanotransduction are extremely limited.
Systematic administration of BMP7 enhances endosteal bone formation in response to 
mechanical loading in a rat tibial bending model, suggesting a possible role of BMP7 in the 
response of bone to mechanical loading in vivo18. A loss-of-function mutation at the BMP7 
locus resulted in BMP7 knockout mice with specific skeletal defects. The most prevalent 
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effect was the failure of one or both of the seventh-pair ribs to fuse with the sternum. 
These results suggest that although BMP7 is not limited to skeletal development, BMP7 is 
involved in bone formation and patterning19,20. Furthermore, primary osteoblasts derived 
from C57BL/6J mice show upregulation of BMP-related genes, i.e., BMP4, BMP receptor 1, 
and BMP receptor 2, after mechanical loading by fluid shear stress12. Moreover, treatment 
with noggin ceases the fluid flow-induced osteoblast proliferation12, indicating that the 
BMP signaling pathway likely contributes to the translation of fluid shear stress into the 
anabolic response of bone. However, thus far it is unknown whether mechanical adaptation 
of bone occurs through BMPs produced by mechanically stimulated osteocytes. To assess 
whether BMPs play a role in the process of mechanotransduction in bone, we studied the 
effect of mechanical loading on BMP production by osteocytes, which are considered the 
prime bone mechanosensor cells1,5,6. We focused on BMP2 and BMP7 since these BMPs are 
currently available as clinically approved recombinant human proteins for bone healing21,22. 
In addition, since BMP7 has a vitamin D receptor (VDR) response element (VDRE)23, we also 
investigated whether VDR is involved in the BMP7 response to mechanical loading. 
MATERIALS AND METHODS
Immunohistochemical Analysis
Four 12-week-old female Wistar rats (235 ± 12 g; Harlan, Zeist, the Netherlands) were killed 
for immunohistochemical analysis. The animal experiment was performed in accordance 
with the governmental guidelines for care and use of laboratory animals and approved 
by the Institutional Animal Care and Use Committee of the VU University Medical Center 
(Amsterdam, the Netherlands). Tibiae from rats were retrieved and fixed with 4% (w/v) 
formaldehyde (buffered in phosphate-buffered saline [PBS], pH 7.4) at 4°C for 24 hours. 
After fixation, the tibiae were decalcified in 10% EDTA containing 0.5% formaldehyde in PBS 
at 4°C for 4.5 weeks. Tibiae were washed in PBS, dehydrated through an ascending series of 
ethanol and xylene at room temperature, and embedded in paraffin. After deparaffination in 
xylene and rehydration in a descending series of ethanol, tissue sections were rinsed in PBS. 
Endogenous peroxidase was blocked by incubation in 3% H2O2 in water for 3 min at room 
temperature. Potential endogenous binding sites for avidin and biotin were blocked using 
a biotin avidin blocking kit (Vector Labs, Burlingame, CA) according to the manufacturer’s 
instructions. Nonspecific binding sites were blocked by incubating tissue sections with 
normal goat serum (30%) for 30 min. Then, sections were incubated overnight at 4°C with 
primary antibodies to BMP224 (1:50) and BMP725 (1:100), kindly donated by Dr. J. Maliakal. 
Recombinant hBMP2 (COP-16, cloned in Escherichia coli) was used to raise the rabbit 
anti-BMP2 (rabbit 88) and recombinant hBMP7 (mature form, cloned in Chinese hamster 
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ovary cells) to raise chicken anti-BMP7 (chicken 881). After rinsing in PBS, tissue sections 
were incubated with biotinylated goat anti-rabbit IgG or biotinylated goat anti-chicken IgG 
(ABC peroxidase technique, Vectastain, Elite kit; Vector Labs) for 1 h at room temperature, 
rinsed, and incubated with ABC–peroxidase complex for 1 h at room temperature. After 
rinsing, the bound peroxidase complex was developed for 6 min at room temperature with 
DAB kit (Vector Labs) and sections were counterstained with hematoxylin. Kidney sections 
were used as a positive control. As a negative control, primary antibodies were replaced by 
normal rabbit or chicken IgG (Vector Labs). 
Primary Human Bone Cells and Primary Mouse Bone Cells
For primary human bone cell isolation, trabecular bone samples (surgical waste) from seven 
female and two male donors (mean age 43, SD 23.7, range 18–84 years) were obtained from 
the proximal femoral shaft during hip replacement surgery for coxarthrosis. The protocol 
was approved by the Ethical Review Board of the VU University Medical Center, and all 
subjects gave informed consent. 
Mouse long bone cells were obtained from the limbs of adult VDR knockout (VDR−/−) 
mice26. To isolate VDR−/− mouse bone cells, VDR−/− mice were generated as described 
previously26 (kindly provided by Dr. G. Carmeliet, Katholieke Universiteit, Leuven, Belgium). 
All mice were bred at the local animal housing facility (Proefdierencentrum, Leuven, Belgium) 
and lived in conventional conditions: 12-h light/dark cycle, standard diet (1% calcium, 
0.76% phosphate), and water ad libitum. All experimental procedures were conducted 
after obtaining formal approval from the ethical committee of the Katholieke Universiteit 
Leuven.  
Human trabecular bone biopsies were placed in sterile PBS, chopped into small 
fragments, and washed extensively with PBS. Long bones from VDR−/− mice were aseptically 
harvested, epiphyses were cut off, and bone marrow was flushed out using a syringe and 
needle. The diaphyses were chopped into small fragments and washed extensively with 
PBS. Human and mouse bone fragments were treated in exactly the same way, as described 
previously27. To obtain outgrowth of the bone cells, bone fragments were cultured in DMEM 
(GIBCO, Grand Island, NY) supplemented with 100 U/ml penicillin (Sigma, St. Louis, MO), 50 
μg/ml streptomycin sulfate (GIBCO), 50 μg/ml gentamicin (GIBCO), 1.25 μg/ml fungizone 
(GIBCO), 100 μg/ml ascorbate (Merck, Darmstadt, Germany), and 10% FBS. After reaching 
subconfluence, outgrowth bone cells were replated at 5 × 103 cells/75 cm2 flask until enough 
cells were obtained. All cells used were from passage 2 or less. For pulsating fluid flow (PFF) 
experiments outgrowth bone cells from humans or VDR−/− mice were harvested and seeded 
at a density of 5 × 105 cells per polylysine-coated (50 μg/ml; poly-l-lysine hydrobromide, 
mol wt 15 to 30 × 104; Sigma) glass slide (5 cm2) and incubated overnight to promote cell 
attachment. 
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Pulsating Fluid Flow
Pulsating fluid flow was generated by pumping 13 ml of culture medium, using a roller pump, 
through a parallel-plate flow chamber as described previously5,8,28. Briefly, fluid shear stress 
of 0.7 ± 0.3 Pa at 5 Hz was induced for 1 h on the monolayer of human and mouse primary 
bone cells by circulating 13 ml of DMEM containing 10% FBS plus antibiotics. Static control 
cultures (Co) were kept in a Petri dish under similar conditions as the experimental cultures. 
After 1 h of PFF or control treatment, human primary bone cells were postincubated without 
PFF (PI) for 1–24 h in 2.5 ml fresh medium and lysed for total RNA isolation or medium was 
collected for extracellular BMP2 and BMP7 protein quantification. VDR−/− mouse primary 
bone cells were lysed directly after 1 hour of PFF for total RNA isolation. 
Nitric Oxide
Nitric oxide (NO) was measured as nitrite (NO2−) accumulation in the medium using Griess 
reagent containing 1% sulfanylamide, 0.1% naphthylethelene-diamine-dihydrochloride, 
and 2.5 M H3PO4. Serial dilutions of NaNO2 in nonconditioned medium were used as a 
standard curve. Absorbance was measured at 540 nm with a microplate reader (Bio-Rad 
Laboratories, Richmond, CA). 
Total DNA Content
Human primary bone cells were lysed with 0.5 ml of ice-cold Milli-Q water, harvested on ice, 
sonicated for 10 min, and centrifuged for 10 min at 2,000 rpm at room temperature. The 
supernatants were analyzed for total DNA content, which was quantified using the Cyquant 
Cell Proliferation Assay (Molecular Probes, Eugene, OR) according to the manufacturer’s 
protocol. 
Analysis of Gene Expression
Gene expression of rat and human BMP2 and BMP7 was analyzed using Taq-Man® Gene 
Expression Assays (Applied Biosystems, Foster City, CA) in an ABI Prism 7700 DNA sequence 
detector. Gene-expression values were normalized for human or mouse GAPDH (Inventoried 
TaqMan, Gene Expression Assays). 
BMP2 and BMP7 Protein Quantification
Immediately after PFF treatment or static control culture, human primary bone cells were 
postincubated without PFF for 6 or 24 h in 1.5 ml fresh culture medium. At 6 and 24 h, 
human BMP2 was quantified in the culture medium using the Quantikine® BMP2 Assay 
(R&D Systems, Minneapolis, MN), and human BMP7 was quantified using the Quantikine 
BMP7 Assay (R&D Systems) according to the manufacturer’s protocol. 
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Statistical Analysis
For statistical analysis of total DNA content and NO data, differences between control and 
PFF groups were tested with Student’s two-tailed t test for paired groups. NO data were 
log-transformed in order to obtain normality. For statistical analysis of PFF treatment or 
mechanical loading-over-static control ratios (PFF/Co), human BMP2 and BMP7 gene 
expression values are expressed as mean ± SEM. Differences of PFF/Co ratios were tested 
with a one-tailed t-test for single group mean and compared to 1 (PFF/control or loading/
control = 1, no difference). Values of the total amount of human BMP2 and BMP7 protein 
are provided as mean ± SEM. Differences between control and PFF groups were tested with 
t test for paired comparison of means. Differences were considered significant if P < 0.05. 
RESULTS
To determine whether osteocytes express BMP2 in vivo, immunohistochemical staining was 
performed in rat tibia (Fig. 1). BMP2 staining was intense in chondrocytes of the resting 
zone and hypertrophic chondrocytes of the growth plate (Fig. 1A). BMP2-positive cells were 
found in bone marrow (Fig. 1B) and trabecular and cortical bone (Fig. 1B). In cortical bone, 
osteoblasts stained positive for BMP2 (Fig. 1B, C), while osteocytes stained either clearly 
positive or completely negative (Fig. 1B, C). No staining was found in negative controls, in 
which nonimmune IgG was replaced by the primary antibody (Fig. 1D). 
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Figure 1. BMP2 expression in rat tibia. (A) BMP2-positive staining (brown) was intense in chondrocytes 
of the resting zone (white arrow) and in hypertrophic chondrocytes of the growth plate (black arrow). 
(B) BMP2-positive cells were found in bone marrow (BM), trabecular bone (TB), and cortical bone (CB). 
In cortical bone, osteoblasts (OB, white arrow) stained positive for BMP2, while osteocytes (OCY, black 
arrows) stained either clearly positive or completely negative. (C) High magnification of cortical bone 
showing osteocytes that stained positive or negative for BMP2. (D) Negative control.
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To assess whether osteocytes express BMP7 in vivo, immunohistochemical staining against 
BMP7 was performed in rat tibia (Fig. 2). BMP7 staining was intense in chondrocytes of the 
resting zone, proliferative zone, and hypertrophic chondrocytes of the growth plate (Fig. 
2A). BMP7-positive cells were found in bone marrow (Fig. 2B) and cortical bone (Fig. 2B). In 
cortical bone osteoblasts stained positive for BMP7 (Fig. 2C). In osteocytes of cortical bone, 
a gradient of staining intensity in BMP7 was observed from the endosteal to the periosteal 
side, with osteocytes showing the highest staining intensity on the endosteal side (Fig. 
2B, C). No staining was found in negative controls, in which nonimmune IgG replaced the 
primary antibody (Fig. 2D).
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Figure 2. BMP7 expression in rat tibia. (A) BMP7-positive staining (brown) was intense in chondrocytes 
of the resting zone (white arrow) and in hypertrophic chondrocytes of the growth plate (black arrow). 
(B) BMP7-positive cells were found in bone marrow (BM) and cortical bone (CB). (C) High magnification 
of cortical bone. (D) Negative control. In cortical bone, a gradient staining intensity of BMP7-positive 
cells was observed, with osteoblasts (OB, white arrow) and osteocytes (OCY, black arrows) at the 
endosteal surface mostly staining positive for BMP7.
To determine whether osteocytes respond to mechanical loading with modulation of BMP2 
and BMP7 gene expression, human primary bone cells were submitted to 1 h of PFF (Fig. 
3). No cells were removed by the fluid flow treatment, as assessed by quantification of 
the DNA content (control 33.4 ± 3.8 ng/ml, PFF 32.5 ± 3.6 ng/ml; P = 0.5). NO release was 
measured after 5 min of PFF as a parameter for bone cell responsiveness. Five minutes of 
PFF treatment rapidly increased NO production by 3.2-fold (P = 0.036, Fig. 3A). One hour 
PFF increased BMP2 gene expression by 1.3-fold, but this value did not reach significance (P 
= 0.2, Fig. 3B). Although BMP2 gene expression levels decreased after 1 h of PFF treatment 
followed by 1–3 h of postincubation without PFF (PI), the values did not reach significance 
(P = 0.1 and P = 0.2, Fig. 3B). In contrast, 1 h PFF followed by 1–3 h of PI upregulated BMP7 
gene expression by 4.4- to 5.6-fold (Fig. 3C), indicating that mechanical loading upregulates 
BMP7 gene expression in human primary bone cells. 
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Figure 3. PFF increases NO production and upregulates gene expression of BMP7, but not BMP2, in 
human primary bone cells. (A) Five minutes of mechanical loading by PFF enhanced NO production. 
(B) PFF did not affect BMP2 gene expression. (C) One hour of PFF followed by 1 and 3 hours of PI 
upregulated BMP7 gene expression. Values were normalized for human GAPDH and expressed as 
mean ± SEM of absolute values and PFF-over-control ratios of five independent donors. PFF pulsating 
fluid flow, Co static control, PI postincubation without PFF. *Significant effect of PFF, P < 0.05.
To verify whether PFF-induced changes in gene expression result in increased protein 
expression, human primary bone cells were submitted to 1 h PFF and postincubated for 
6–24 h without PFF (Fig. 4). Under static control conditions, human bone cells produce 
144.6 ± 1.6 pM BMP2 protein (Fig. 4A), while basal levels of BMP7 protein are 12.2 ± 1.1 
pM (Fig. 4B). This indicates that human primary bone cells produce 11.8-fold more BMP2 
than BMP7 (P = 0.001) under static control conditions. One hour PFF followed by 6–24 h of 
PI did not change BMP2 protein levels when compared to static controls (Fig. 4A). However, 
1 h PFF followed by 6 h PI significantly upregulated BMP7 protein levels by 2.4-fold (Fig. 4B). 
To investigate how osteocytes increase BMP7 production in response to mechanical 
loading, VDR−/− mouse primary bone cells were submitted to mechanical loading by PFF 
in vitro (Fig. 5). NO release was measured after 5 min of PFF as a parameter for bone cell 
responsiveness. Five minutes of PFF treatment increased NO production by 1.8-fold (P = 
0.023, Fig. 5A). Our preliminary data on BMP7 gene expression show that PFF did not change 
BMP7 gene expression in these cells (Fig. 5B), suggesting that the VDR mediates mechanical 
loading-induced upregulation of BMP7 in osteocytes.
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Figure 4. PFF upregulates protein expression of BMP7, but not BMP2, in human primary bone cells. 
(A) PFF did not affect protein expression of BMP2. (B) One hour of PFF followed by 6 and 3 hours of 
PI upregulated BMP7 protein expression. Values were expressed as mean ± SEM of PFF-over-static 
control ratios of five independent donors. PFF, pulsating fluid flow; Co, static control; PI, postincubation 
without PFF. *Significant effect of PFF, P < 0.05.
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Figure 5. PFF increases NO production but does not alter gene expression of BMP7 in VDR−/− mouse 
primary bone cells. (A) 5 min of mechanical loading by PFF enhanced NO production. (B) PFF did 
not affect gene expression of BMP7 in VDR−/− mouse primary bone cells. Values were normalized for 
mouse GAPDH and expressed as mean ≤ SEM of absolute values and PFF-over-control ratios of three 
independent donors. PFF pulsating fluid flow, Co static control. *Significant effect of PFF, P < 0.05.
DISCUSSION
Bone is a living tissue that is able to adapt its mass and structure to mechanical demands 
throughout life2. Osteocytes are proposed as the key cells that convert the physical stimuli 
resulting from daily loading into a biological signal by the secretion of signaling molecules 
in a process known as mechanotransduction1,5,8. These mechanostimulated molecules 
activate a wide spectrum of signaling pathways fundamental for bone resorption by 
osteoclasts and/or bone formation by osteoblasts12. BMPs represent a class of key proteins 
for the regulation of cell–cell communication, cell differentiation, and morphogenesis 
of several organs13,29. In bone, BMPs are multifunctional regulators of proliferation and 
differentiation during development30,31 and are required for osteoblast gene expression and 
differentiation30–33. BMPs represent one of the most studied growth factors due to their 
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relevance in bone regeneration. However, it is unclear what role BMPs, specifically BMP2 
and BMP7, play in the process of bone mechanotransduction. Therefore, we studied the 
effect of mechanical loading on BMP production by osteocytes, which are considered the 
prime bone mechanosensor cells1, 3–5.
We used human primary bone cells obtained as outgrowth from collagenase-stripped 
bone pieces to study whether osteocytes in vitro respond to mechanical loading with 
production of BMP2 and BMP7. Although the exact nature of the outgrowth cells is not 
completely known, human primary bone cells may be considered bone cells since they 
express alkaline phosphatase, cfba-I32,33, and osteocalcin32-34. In addition, these cells respond 
to mechanical loading with increased expression of COX-223, indicating that these bone cell 
cultures have an osteocyte-like phenotype since mechanical loading induces increased gene 
expression of COX-2 in chicken osteocytes but not osteoblasts35. Furthermore, these cells 
express detectable levels of MEPE, DMP1, and SOST (unpublished observations), which are 
considered osteocyte markers36. 
We found that PFF, representing a physiological loading regime28, significantly increased 
BMP7, but not BMP2, gene and protein expression in human osteocytes, indicating that 
upregulation of BMP7 represents a physiological response to mechanical loading of bone. 
Our findings are supported by the observation of others that load-induced bone formation 
in vivo is enhanced by BMP718, indicating that BMP7 might be an essential molecule in the 
process of mechanically driven bone formation. 
Contradictory data have been reported on the effects of mechanical loading on 
BMP production in bone. Compressive forces and shear stress upregulate expression 
of BMPs 2, 4, 6, and 7 in osteoblasts in vitro12,37. Upregulation of BMPs 2, 4, and 6 was 
observed during distraction osteogenesis; but BMP7 expression did not change during the 
distraction38. Mechanical tension during distraction osteogenesis in vivo increases BMP2 
and BMP4, but not BMP7, gene expression39. These observations differ from our results, 
showing that mechanical loading stimulated BMP7, but not BMP2, expression in cultured 
osteocytes. In addition, we assessed expression of BMP4 and BMP6 (data not shown). 
BMP4 gene expression seemed to be reduced after PFF treatment. BMP6 gene-expression 
data were not consistent; therefore, we cannot exclude a role for BMP6 in the anabolic 
response of osteocytes to mechanical loading. It is generally accepted that osteocytes are 
the primary sensors of mechanical loading in bone, rather than osteoblasts1,5-8. Osteocytes 
and osteoblasts respond differently in terms of loading-induced production of signaling 
molecules2,8,11. Therefore, differences in mechanical loading regimes and characteristics 
between osteocytes and osteoblasts might explain the differences in loading-induced BMP 
expression between experiments. 
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To investigate how osteocytes increase BMP7 production in response to mechanical loading, 
we searched for signaling pathways that are activated upon loading and could mediate 
this response. Since both BMP7 protein expression and gene expression were affected by 
loading, we focused on signaling pathways that activate the BMP7 promoter sequence. 
BMP2 gene expression remained unchanged, but BMP7 gene expression and protein 
expression were affected by mechanical loading, although BMPs are highly conserved 
proteins. Thus, we focused on possible differences between the promoter region of BMP2 
and BMP7. The BMP7, but not the BMP2, promoter does contain VDREs23. Therefore, we 
hypothesized that the VDR is involved in the increase in BMP7 gene expression in response 
to mechanical loading. To test our hypothesis, VDR−/− mouse primary bone cells26 were 
submitted to mechanical loading by PFF in vitro. Our data show that PFF does not change 
BMP7 gene expression in these cells (Fig. 5), suggesting that the VDR mediates mechanical 
loading-induced upregulation of BMP7 in osteocytes. Although VDR−/− mouse primary bone 
cells were derived from mice rather than humans, they were obtained in exactly the same 
manner. In addition, mouse and human primary bone cells show the same response to 
mechanical loading as illustrated by the increased NO production in response to mechanical 
loading. 
It is well established that bone cells and chondrocytes produce BMPs13. Similar to 
observations by others, we also show moderate to intense expression of BMP2 and BMP7 
in bone marrow cells, bone lining cells, osteoblasts, and osteocytes40,41. We observed a 
gradient of BMP7 expression, varying from intense staining at the endosteal side to no 
staining at the periosteal side of cortical bone. In addition, basal levels of BMP2 expression 
were significantly higher than basal BMP7 expression in cultured human osteocytes, and 
BMP7, but not BMP2, was produced in response to mechanical loading. Since BMP2 is 
essential for recruitment of bone marrow cells and initial cell lineage commitment, while 
BMP7 has a relevant role in the maturation process of preosteoblasts, these finding might 
have implications for bone remodeling. However, the role of BMPs in bone remodeling is 
not fully understood. BMP2 is produced by bone marrow stromal cells and necessary for 
osteoblast differentiation40,41. Cheng and colleagues42 reported an osteogenic hierarchy 
where BMPs 2, 6, and 9 are the most potent agents to induce osteoblast lineage-specific 
differentiation of mesenchymal progenitor cells, while most BMPs can promote the terminal 
differentiation of committed osteoblast precursors and osteoblasts. BMP7 increases bone 
formation primarily by promoting preosteoblast growth and differentiation without affecting 
bone matrix production by individual osteoblasts in vitro43. Systemic administration of BMP7 
stimulates the differentiation of bone lining cells, fibroblasts, and other committed cells to 
osteoblasts but does not increase putative stem cell proliferation18. Thus, it is possible that 
the mature cells of the osteoblastic lineage, i.e., the osteocytes, respond to mechanical 
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loading with increased BMP7 production to enhance differentiation of already committed 
osteogenic cells, while high basal BMP2 expression guarantees the differentiation of bone 
marrow cells into preosteoblasts. In other words, BMP2 seems to be essential for general 
bone formation, while BMP7 is required for local bone formation in response to mechanical 
loading. Future functional studies are needed to assess the precise functional role of loading-
induced BMP7 production in bone (re)modeling. 
In bone biology, the mechanisms by which bones adapt to mechanical demands are 
still a challenging area of research. We show for the first time that physiological loading 
regimes induce increased BMP7 gene and protein expression in osteocytes, the bone 
mechanosensor cells. Basal BMP2 protein expression levels were significantly higher than 
BMP7 levels in osteocytes, while mechanical loading did not affect BMP2 gene or protein 
expression. Thus, it is likely that BMP7 plays a role in mechanotransduction in osteocytes. 
Our data might contribute to a better understanding of the mechanisms that lead to bone 
mechanical adaptation. Unraveling the signaling pathways that lead to an optimal response 
to physiological loading regimes might provide new insights for therapeutic approaches in 
bone biology. 
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ABSTRACT
1,25-dihydroxyvitamin D
3 
(1,25(OH)
2
D
3
) strongly mediates bone mass. Mechanical 
stimulation also affects bone mass, partly via enhancing nitric oxide (NO) production by 
osteoblasts. We aimed to determine whether 1,25(OH)
2
D
3 
affects NO production by 
osteoblasts in the presence or absence of mechanical stimulation. We hypothesised that 
1,25(OH)
2
D
3
 stimulates NO production via nuclear actions of the vitamin D receptor (VDR), 
which requires hours of incubation with 1,25(OH)
2
D
3
 to occur. MC3T3-E1 osteoblasts and 
long-bone osteoblasts of adult wildtype and VDR-/- mice were pre-incubated for 24h with 
or without 1,25(OH)
2
D
3 
(10-13-10-9 M), followed by 30 min pulsating fluid flow (PFF; 0.7±0.3 
Pa, 5 Hz) or static culture with or without 1,25(OH)
2
D
3
. NO production and NO synthase 
(NOS) expression were quantified. 10-11 M 1,25(OH)
2
D
3 
for 24h, but not 30 min, stimulated 
NO production by MC3T3-E1 osteoblasts (8-fold). 1,25(OH)
2
D
3 
for 24 h increased inducible-
NOS gene-expression (2-fold), suggesting that 1,25(OH)
2
D
3 
stimulated NO production via 
activation of NOS gene transcription. PFF rapidly increased NO production by MC3T3-E1 
osteoblasts, wildtype osteoblasts, and VDR-/- osteoblasts. This PFF effect was abolished 
after incubation with 1,25(OH)
2
D
3 
for 24 h, or during PFF only. Our results suggest that 
1,25(OH)
2
D
3 
stimulates inducible-NOS expression and NO production by osteoblasts in the 
absence of mechanical stimulation, likely via genomic VDR action. In contrast, 1,25(OH)
2
D
3
 
may affect mechanical loading-induced NO production independent of genomic VDR action, 
since 1,25(OH)
2
D
3
 diminished PFF-induced NO production in VDR-/- bone cells. In conclusion, 
1,25(OH)
2
D
3 
and mechanical loading interact at the level of mechanotransduction, whereby 
1,25(OH)
2
D
3 
seems to act independently of VDR genomic mechanism. 
Key words Osteoblasts; mechanical loading; 1,25-dihydroxyvitamin D
3
; vitamin D receptor; 
VDR-/- mice; nitric oxide synthase.
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INTRODUCTION
1,25-Dihydroxyvitamin D
3 
(1,25(OH)
2
D
3
) is a steroid hormone, which serves as a signalling 
molecule in almost every human tissue, including bone1. The action of 1,25(OH)
2
D
3
 on bone 
is ambiguous. On the one hand, 1,25(OH)
2
D
3 
increases bone mineralization, stiffness, and 
strength directly via stimulation of calcium and phosphate supply, mainly by absorption 
from the gut2. On the other hand, 1,25(OH)
2
D
3 
has clear direct effects on osteoblasts 
and osteoclasts3. 1,25(OH)
2
D
3
 not only stimulates osteocalcin and alkaline phosphatase 
production by osteoblasts3, but also affects osteopontin expression in osteoblasts4, and bone 
resorption in vitro. Considering the biological significance of 1,25(OH)
2
D
3
 in the regulation of 
bone mass, it is surprising how little is known about the mechanism by which it stimulates 
bone mass, and how the actions of 1,25(OH)
2
D
3
 on bone interact with other bone mass-
regulating factors, such as mechanical loading.
The genomic responses to 1,25(OH)
2
D
3
 are mediated by the formation of a ligand-
receptor complex of 1,25(OH)
2
D
3
 with the vitamin D receptor (VDR), a member of the 
super-family of steroid hormone nuclear receptors5. The specific binding of 1,25(OH)
2
D
3 
to nuclear components of small intestinal mucosa was demonstrated for the first time 
in vitamin D-deficient chicks6. In addition to the VDR-mediated actions, 1,25(OH)
2
D
3
 
seems to mediate cellular responses via a non-VDR mediated mechanism. These non-
VDR mediated cellular responses to 1,25(OH)
2
D
3
 appear to be facilitated by a variety of 
receptor types located within or near the plasma membrane or caveolae7. The existence 
of a specific 1,25(OH)
2
D
3
 membrane coupled receptor is subject of debate8, although a 
possible receptor for 1,25(OH)
2
D
3
 was isolated from chick intestinal basolateral membranes 
and called 1,25(OH)
2
D
3
-membrane-associated rapid response to steroid (1,25D
3
-MARRS)9. 
The membrane receptor associated rapid responses to 1,25(OH)
2
D
3
, which are mediated 
by 1,25D
3
-MARRS or other receptors, include activation of phospholipase A2, increased 
membrane fluidity, and activation of phospholipase C, leading to activation of protein kinase 
C and release of intracellular calcium10,11, and vary in response time from seconds (opening 
of ion channels) to 10-60 min. In contrast, the VDR-mediated genomic actions of 1,25(OH)
2
D
3
 
take generally much longer, i.e. hours, to occur. Recently it was demonstrated that 25(OH)D
3
 
is equipotent to 1,25(OH)
2
D
3
 in opening calcium channels12. These new findings suggest the 
ability of 25(OH)D
3
 as well as 1,25(OH)
2
D
3 
to generate biological responses in vivo12.
The VDR-mediated genomic actions of 1,25(OH)
2
D
3
 occur by coupling of the VDR to 
VDR response elements (VDRE) in the promoter regions of 1,25(OH)
2
D
3
 target genes1. 
Genes containing a VDRE often encode for proteins involved in the regulation of osteoclast 
formation and/or activity, or osteoblast differentiation, such as RANKL or nitric oxide synthase 
(NOS)13. Three NOS isoforms are known, endothelial NOS (ecNOS), neuronal NOS (nNOS), 
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and inducible NOS (iNOS)14,15. NOS is responsible for the synthesis of nitric oxide (NO) from 
L-arginine16. NO is a short-lived free radical with an important physiological role in the skeletal 
system15. NO stimulates osteoblast activity, e.g. 17β-estradiol dose-dependently stimulates 
proliferation and differentiation of cultured primary human and rat osteoblasts, which is 
abolished by inhibition of NOS activity17. 1,25(OH)
2
D
3
 is a steroid hormone like 17β-estradiol 
and androgens, which are known to stimulate NO production in osteoblasts18,19. Therefore 
1,25(OH)
2
D
3
 might also stimulate NO production. Indeed 1,25(OH)
2
D
3 
has been shown to 
modulate iNOS expression in rat brain cells20,21. Therefore some of the effects of 1,25(OH)
2
D
3
 
on bone might be mediated by enhanced NO production by osteoblasts and/or osteoclasts, 
or by bone cells in close proximity to osteoblasts and osteoclasts, such as osteocytes.
Both 1,25(OH)
2
D
3
 and mechanical loading of bone positively affect bone mass. 
Importantly, the NO production by mechanosensitive cells is essential for the anabolic effect 
of mechanical loading on bone. The increase in bone mass as a result of mechanical loading-
induced NO production likely occurs as follows. When load is applied to bone, the deformation 
of the bone matrix will result in a flow of the thin layer of interstitial fluid that surrounds the 
network of osteocytes lying in the calcified bone matrix22,23. As a result, mechanosensitive 
bone cells produce signalling molecules, amongst others NO, that signal to the osteoblasts 
and/or osteoclasts to change their bone remodelling activities24. Interestingly, 1,25(OH)
2
D
3
 
and mechanical loading may interact at the cellular level to increase bone mass25. 
It is unknown whether 1,25(OH)
2
D
3
 affects NO production by osteoblasts, and if so, 
whether this effect occurs via genomic actions of the VDR. Since mechanical stimulation 
is known to enhance NO production by osteoblasts, and 1,25(OH)
2
D
3 
and mechanical 
loading may show interaction at the cellular level in the regulation of bone mass, the aim 
of the present study was to determine whether 1,25(OH)
2
D
3 
affects the production of 
NO by osteoblasts that are either or not mechanically stimulated. We hypothesised that 
1,25(OH)
2
D
3
 stimulates NO production by osteoblasts via nuclear actions of the vitamin D 
receptor (VDR), rather than via rapid membrane receptor-mediated mechanisms.
MATERIALS AND METHODS
Osteoblast culture
MC3T3-E1 cells were cultured in α-minimal essential medium (α-MEM; Gibco, Paisly, UK) 
supplemented with 100 U/ml penicillin (Sigma-Aldrich, St. Louis, MO, USA), 50 µg/ml 
streptomycin (Sigma-Aldrich), 1.4 mM L-glutamine (Sigma), 9 mM β-glycerophosphate 
(Sigma-Aldrich), 1.9 mM ascorbate (vitamin C; Merck, Darmstadt, Germany), and 10% fetal 
bovine serum (FBS; Gibco). Cells were cultured with or without 1,25(OH)
2
D
3 
and used for 
pulsating fluid flow (PFF) experiments as described below.
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Osteoblasts from wildtype and VDR-/- mice
Mice were bred at the local animal housing facility (“Proefdierencentrum”, Leuven, Belgium), 
and living under conventional conditions, i.e. standard diet (1% calcium, 0.76% phosphate), 
and water ad libitum. All experimental procedures were conducted after approval was 
obtained from the ethical committee of the Katholieke Universiteit Leuven. Mouse long 
bone cells were obtained from the limbs of adult VDR-/- [26] and wildtype (wt) littermates. 
Long bones were aseptically harvested, chopped into small fragments, and incubated with 
collagenase II (Sigma) at 2 mg/ml in Dulbecco’s modified Eagle’s medium (DMEM; Gibco) at 
37°C in a shaking water bath. Bone fragments were washed with medium containing 10% FBS 
and transferred to 25 cm2 flasks (Nunc, Roskilde, Denmark). Bone fragments were cultured 
in DMEM supplemented with 100 U/ml penicillin (Sigma), 50 µg/ml streptomycin sulfate 
(Gibco), 50 µg/ml gentamicin (Gibco), 1.25 µg/ml fungizone (Gibco), 100 µg/ml ascorbate, 
and 10% FBS. Cells were used at passage 1 for 1,25(OH)
2
D
3 
treatment and PFF-experiments. 
1,25(OH)2D3 treatment
Cells were seeded onto polylysine-coated (50 µg/ml; poly-L-lysine hydrobromide, mol wt 15-
30 x 104; Sigma) glass slides (size 2.5x6.5 cm) at 2x105 cells/glass slide, and cultured overnight 
in petridishes with 13 ml α-MEM plus supplements as described under “osteoblast culture”. 
Next the culture medium was replaced by α-MEM (MC3T3-E1) or DMEM (osteoblasts from 
wt or VDR-/- mice) containing 0.2% bovine serum albumin (BSA), antibiotics, ascorbate, and 
0, 10-9, 10-11, or 10-13 M 1,25(OH)
2
D
3
 for 24 h. 1,25(OH)
2
D
3
 was dissolved in 100% ethanol, 
and media for all treatment and control groups contained 0.001% ethanol. Cells were then 
either lysed for total RNA isolation or used for PFF treatment.
Pulsating fluid flow (PFF)
PFF was applied as described earlier18. Briefly, PFF was generated by pumping 13 ml of 
culture medium containing 0, 10-9, 10-11, or 10-13 M 1,25(OH)
2
D
3
 through a parallel-plate flow 
chamber containing osteoblasts. Osteoblasts were subjected for 30 min to a 5 Hz pulse with 
a mean shear stress of 0.7 Pa, a pulse amplitude of 0.3 Pa, and a peak shear stress rate of 
8.4 Pa/s. Stationary control cultures were kept in a petridish under similar conditions as 
experimental cultures. After 5, 10, 15, and 30 min of PFF or static control culture, medium 
was collected and assayed for NO concentrations. 
Nitric oxide (NO)
NO was measured as nitrite (NO
2
-) accumulation in the medium using Griess reagent 
containing 1% sulfanylamide, 0.1% naphtylethelene-diamine-dihydrochloride, and 2.5 M 
H
3
PO
4
. Serial dilutions of NaNO
2
 in non-conditioned medium were used as a standard curve. 
Absorbance was measured at 540 nm with a microplate reader (BioRad Laboratories Inc.).
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Total RNA, total protein, and cDNA synthesis
RNA and protein were isolated using TRIzol reagent (Gibco) according to the manufacturer’s 
instructions. The RNA content was determined by measuring the absorbance in water at 260 
nm using an Ultrospec III spectrophotometer (Amersham). cDNA synthesis was performed 
using 1 μg total RNA in a 20 μl reaction mix consisting of 5 units Transcriptor Reverse 
Transcriptase (Roche Diagnostics), 0.08 A
260
 units random primers (Roche Diagnostics), 
1 mM of each dNTP (Invitrogen), and 1x concentrated Transcriptor RT reaction buffer (Roche 
Diagnostics). 
Analysis of gene expression
Gene expression of mouse iNOS, nNOS, and ecNOS was analyzed using Taqman® Gene 
expression assays (Inventoried Taqman® Gene expression assays, Applied Biosystems) in 
an ABI Prism 7700 sequence detector (Applied Biosystems). Gene expression values were 
normalized for mouse GAPDH (Inventoried Taqman® Gene expression assays, Applied 
Biosystems).
Statistical analysis
Data on the effect of 24 h 1,25(OH)
2
D
3 
was obtained from 6 experiments, and data on the 
effect of 30 min 1,25(OH)
2
D
3
 during PFF or static culture from 5 experiments. Data using 
primary mouse bone cells was obtained from 6 VDR-/- and 4 wild type mice. NO data are 
expressed as absolute values, and as PFF-treated-over-static control ratios. Data were 
analysed using the Wilcoxon signed-rank test for paired observations. Differences were 
considered significant if p<0.05. All data are expressed as mean ± SEM.
RESULTS
We first tested whether 1,25(OH)
2
D
3
 affects NO production by MC3T3-E1 osteoblasts 
cultured under static conditions. Twenty-four hour incubation with 1,25(OH)
2
D
3
 stimulated 
NO production by MC3T3-E1 osteoblasts (Fig. 1A), with a maximal 8-fold stimulation by 10-11 
M 1,25(OH)
2
D
3
 at 30 min. 
Thereafter we investigated whether 1,25(OH)
2
D
3
 stimulated NOS gene expression. 
MC3T3-E1 osteoblasts were cultured with or without 1,25(OH)
2
D
3
 for 24 h, and NOS gene 
expression was determined. 1,25(OH)
2
D
3 
at 10-9 M increased iNOS gene expression by 2 
fold (p=0.049, n=3), and 10-11 M 1,25(OH)
2
D
3 
showed a similar trend (p=0.06, n=3, Fig. 1B). 
1,25(OH)
2
D
3
 at all concentrations tested did not alter nNOS or ecNOS gene expression (data 
not shown). 
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We then investigated whether 1,25(OH)
2
D
3
 affects mechanical loading-induced NO 
production. MC3T3-E1 osteoblasts were cultured for 24 h in the presence or absence of 
1,25(OH)
2
D
3
 and subjected to 30 min of PFF. PFF caused a rapid increase in NO production 
immediately after the start of PFF treatment in the absence of 1,25(OH)
2
D
3 
(Fig. 1C). 
Twenty-four h incubation with 1,25(OH)
2
D
3 
at all concentrations tested (10-9, 10-11, 10-13 M) 
significantly inhibited the PFF-induced NO production by 3-9 fold at 10 min (Fig. 1C). 
Figure 1. Twenty-four hour incubation with 1,25(OH)
2
D
3
 (10-11M) stimulated NO production and 
iNOS gene expression, and inhibited mechanical loading-stimulated NO production by MC3T3-E1 
osteoblasts. (A) 1,25(OH)
2
D
3
 induced NO production measured during the last 30 min of a 24 h 
incubation period with 1,25(OH)
2
D
3
. (B) 1,25(OH)
2
D
3
 induced iNOS gene expression. (C) 1,25(OH)
2
D
3
 
inhibited mechanical loading-stimulated NO production. Values are mean ± SEM of 6 independent 
experiments. * Significant effect of 1,25(OH)
2
D
3
 on NO-production, p<0.05.
We verified whether genomic actions of the VDR were responsible for the inhibiting effect 
of 1,25(OH)
2
D
3
 on PFF-induced NO production. To this end, we incubated wt and VDR-/- 
osteoblasts for 24 h with 10-13 M 1,25(OH)
2
D
3
, which is the lowest concentration affecting 
PFF-induced NO production in MC3T3-E1 osteoblasts, and subjected the cells to PFF. 
1,25(OH)
2
D
3
 did not stimulate NO production by wt or VDR-/- osteoblasts under static culture 
conditions, which is similar to our findings in MC3T3-E1 osteoblasts. PFF stimulated NO 
production in wt osteoblasts (p=0.006) (Fig. 2A) and VDR-/- osteoblasts (p= 0.006) (Fig. 2B). 
Remarkably 1,25(OH)
2
D
3 
inhibited mechanical loading-induced NO production in both wt 
(p=0.02) and VDR-/- osteoblasts (p=0.04) (Fig. 2B).  
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Figure 2. Effect of 24 h incubation with 1,25(OH)
2
D
3
 (10-13M) on mechanical loading-induced NO-
production by wildtype and VDR-/- osteoblasts. (A) PFF stimulated NO producyion by wt mouse long 
bone cells by 2-fold (p=0.006). 1,25(OH)
2
D
3 
inhibited the mechanical loading-induced NO production 
(p=0.02). (B) PFF stimulated NO production by VDR-/- mouse long bone cells by 2-fold (p=0.02). 
1,25(OH)
2
D
3
 decreased mechanical loading-induced NO production by VDR-/- mouse long bone cells 
(p=0.04). Values are mean ± SEM of 4 independent experiments. wt, wildtype; VDR-/-, VDR knockout. 
These results suggest that the effect of 1,25(OH)
2
D
3
 on PFF-induced NO production is not 
mediated via genomic actions of the VDR, but possibly via membrane-associated actions. 
Since membrane receptor-mediated responses to 1,25(OH)
2
D
3
 occur within seconds to 
minutes, we investigated whether incubation with 1,25(OH)
2
D
3 
for only 30 min is sufficient 
to stimulate NO production in MC3T3-E1 osteoblasts, and whether this short incubation 
affects PFF-induced NO production. Thirty min of incubation with 1,25(OH)
2
D
3 
did not 
induce NO production by MC3T3-E1 osteoblasts at any of the concentrations tested (Fig. 
3A). 1,25(OH)
2
D
3 
at 10-11 M significantly inhibited the PFF-induced NO production by 2-fold 
at 10 min (p=0.004) and 30 min (p=0.006) (Fig. 3B). A similar trend was observed at later 
time points, where 1,25(OH)
2
D
3
, at all concentrations tested (10-9, 10-11, 10-13 M) seemed to 
decrease PFF-induced NO production (Fig. 3B). 
Figure 3. Effect of 30 min of 1,25(OH)2D3 (10-13M) treatment on NO production and mechanical 
loading-induced NO production by MC3T3-E1 osteoblasts. (A) Thirty min of 1,25(OH)2D3 (10-13M) did 
not induce NO production in osteoblasts. (B) PFF stimulated NO production by MC3T3-E1 osteoblasts. 
Thirty min of 1,25(OH)2D3 (10-13M) treatment inhibited the mechanical loading-induced NO production 
by 4-fold. Values are mean ± SEM of absolute values of 6 independent experiments. * Significant effect 
of 1,25(OH)2D3 on NO production, p<0.05.
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DISCUSSION
Both 1,25(OH)
2
D
3
 and mechanical loading are essential regulators of bone mass. 
Disturbances of 1,25(OH)
2
D
3
 metabolism as well as disturbed mechanical adaptation have 
been linked to the emergence of osteoporosis27,28. It is known that the positive effect of 
mechanical loading on bone mass is mediated, at least in part, by NO. Whether NO plays a 
similar role in mediating the effects of 1,25(OH)
2
D
3
 on bone mass is unknown, but several 
arguments derived from literature are in favour of this hypothesis20,21,29. Therefore we 
investigated whether 1,25(OH)
2
D
3
 affects NO production by osteoblasts, as well as the 
effect of 1,25(OH)
2
D
3
 on the NO response to mechanical loading, and whether this effect 
is dependent on genomic actions of the steroid receptor VDR. We found a stimulating 
effect of 10-11 M 1,25(OH)
2
D
3
 on NO production by osteoblasts under static culture without 
mechanical stimulation, but the highest concentration tested (10-9 M) did not affect NO 
production. Often a biphasic response to 1,25(OH)
2
D
3 
is seen, with an optimum at mid-range 
concentrations, i.e. higher concentrations of 1,25(OH)
2
D
3
 are not necessarily leading to a 
stronger effect. We reasoned that the NOS isoform responsible for 1,25(OH)
2
D
3
-induced 
NO production may be iNOS, since 1,25(OH)
2
D
3 
modulates iNOS expression in microglial 
cells and the brain20,21,29. We found that 24 h incubation with 1,25(OH)
2
D
3
 indeed increased 
iNOS gene expression in osteoblasts, but did not change nNOS or ecNOS gene expression. 
This suggests that the effect of 10-11 M 1,25(OH)
2
D
3
 on NO production was mediated via 
enhanced iNOS gene expression, although we cannot exclude that 1,25(OH)
2
D
3 
enhanced 
ecNOS or nNOS activity rather than transcription. iNOS gene transcription, but not NO 
production, was increased by 10-9 M 1,25(OH)
2
D
3
. We speculate that the concentration of 
10-9 M 1,25(OH)
2
D
3
, which is higher than the free available concentration of 1,25(OH)
2
D
3
 
in the human body (50-180 pmol/L)30, may be supra-physiologic and either inhibits iNOS 
activity by limiting substrate availability or inhibits iNOS protein synthesis, as 1,25(OH)
2
D
3
 
affects protein translation by targeting the mTOR pathway31. 
1,25(OH)
2
D
3
 has direct actions on bone cells via the VDR32. However, it seems that not 
all actions of 1,25(OH)
2
D
3 
on bone are mediated via the VDR. For example, studies in VDR 
knockout mice show that 1,25(OH)
2
D
3
 affects skeletal mineralization independent of the 
VDR33. These studies do not clarify whether a membrane-associated VDR is responsible 
for the VDR-independent actions of 1,25(OH)
2
D
3. 
However earlier studies did show 
evidence for a rapid, i.e. within seconds to minutes, activation of signalling pathways by 
1,25(OH)
2
D
3
, possibly indicating activity of a membrane-type receptor 
12. However, it was 
demonstrated that 1,25(OH)
2
D
3
 elicited electrical activity via a functional VDR32. The kinase 
and second messenger pathways activated by rapid 1,25(OH)
2
D
3
-mediated signalling include 
phospholipase A and C, protein kinase C and increase of intracellular calcium10,11. Similar 
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signalling cascades are activated by mechanical stimuli34,35, supporting the notion that 
1,25(OH)
2
D
3
 and mechanical loading may interact. In addition, an important early response 
of osteoblasts to mechanical loading is a rise in intracellular calcium concentration, which 
is necessary for activation of calcium/calmodulin-dependent enzymes such as ecNOS and 
nNOS. When serum levels of calcium are low, 1,25(OH)
2
D
3 
stimulates calcium absorption 
from the gut, thereby increasing serum calcium36. This increase in serum calcium may also 
facilitate an increase in intracellular calcium concentrations in osteoblasts, which could be 
beneficial to the activation of NOS in response to mechanical loading. Interestingly, the 
NO response of MLO-Y4 osteocytes to mechanical loading is inhibited in the presence of 
EGTA, which lowers extracellular calcium concentrations18. This also supports the notion 
that 1,25(OH)
2
D
3
 and mechanical loading may interact at the cellular level in the regulation 
of bone mass.
It has long been a matter of debate whether the non-genomic actions of 1,25(OH)
2
D
3 
are 
mediated by another receptor than the classical VDR13. We found that 1,25(OH)
2
D
3
 inhibited 
the NO-response to mechanical loading in VDR-/- osteoblasts. These VDR-/- osteoblasts might 
still express a truncated form of the VDR that is unable to exert its genomic actions37, but 
can still bind 1,25(OH)
2
D
3 
and exert a rapid membrane response. It is also possible that 
there is a separate membrane-associated receptor e.g. MARRS, mediating the inhibition of 
mechanical loading-induced NO production by 1,25(OH)
2
D
3
. Moreover, the VDR was also 
found to be localized near the plasma membrane in caveolae38, leading to the proposal that 
the VDR directs also non-genomic signalling. Modelling studies of the VDR ligand-binding 
domain showed that the VDR could possibly accept and favour non-bonding interactions 
with vitamin D sterols in a distinct ligand-binding pocket from the genomic pocket that 
was previously defined by x-ray crystallography39,40. NO production by osteoblasts was 
differentially affected by 1,25(OH)
2
D
3
 dependent on the time of incubation. Only 24 h of 
incubation with 1,25(OH)
2
D
3
 increased NO production by osteoblasts cultured under static 
conditions, suggesting that the response was facilitated via the genomic VDR. In contrast, 
1,25(OH)
2
D
3
 administered for only 30 min during PFF reduced mechanical loading-stimulated 
NO production by osteoblasts. This response is rapid, and therefore it is unlikely that the 
genomic pathway mediated the effects of 1,25(OH)
2
D
3 
on PFF-induced NO production in 
osteoblasts
.
 
In summary, our results suggest that 1,25(OH)
2
D
3 
stimulates iNOS expression and 
NO production by osteoblasts, likely via genomic actions of the VDR (Fig. 4). Moreover 
1,25(OH)
2
D
3 
and mechanical loading interact at the level of mechanotransduction, whereby 
1,25(OH)
2
D
3 
modulation of mechanical loading-induced NO production occurs via a 
mechanism independent of genomic actions of the VDR. 
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Figure 4. 1,25(OH)2D3 (1,25D3) stimulates iNOS expression and NO production by osteoblasts, likely 
via genomic actions of the VDR. Mechanical loading (PFF) stimulates NO production via an increase in 
intracellular calcium and ecNOS activation. 1,25(OH)2D3 and mechanical loading interact at the level 
of mechanotransduction, whereby 1,25(OH)2D3 inhibits mechanical loading-induced NO production, 
likely independent of genomic actions of the VDR. Other second messenger pathways activated by this 
non-genomic 1,25(OH)2D3-mediated signalling include PLA, PLC, PKC and intracellular calcium (Ca2+i), 
which are also activated by mechanical loading.
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ABSTRACT
The response of bone cells to mechanical loading is mediated by the cytoskeleton. Since the 
bone anabolic agent fluoride disrupts the cytoskeleton, we investigated whether fluoride 
affects the response of bone cells to mechanical loading, and whether this is cytoskeleton-
mediated. The mechano-response of osteoblasts was assessed in vitro by measuring 
pulsating fluid flow-induced nitric oxide (NO) production. Osteocyte shape was determined 
in hamster mandibles in vivo as parameter of osteocyte mechanosensitivity. Pulsating 
fluid flow (0.7±0.3 Pa, 5 Hz) stimulated NO production by 8-fold within 5 min. NaF (10-50 
µM) inhibited pulsating fluid flow-stimulated NO production after 10 min, and decreased 
F-actin content by ~3-fold. Fluid flow-induced NO response was also inhibited after F-actin 
disruption by cytochalasin B. NaF-treatment resulted in more elongated, smaller osteocytes 
in interdental bone in vivo. Our results suggest that fluoride inhibits the mechano-response of 
bone cells, which might occur via cytoskeletal changes. Since decreased mechanosensitivity 
reduces bone mass, the reported anabolic effect of fluoride on bone mass in vivo is likely 
mediated by other factors than changed bone cell mechanosensitivity.
Key words: Fluoride; mechanical loading; nitric oxide; cytoskeleton; osteocytes.
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INTRODUCTION
Bone is a living tissue capable of adapting its mass and structure to the demands of 
mechanical usage1. Mechanical adaptation is orchestrated by the osteocytes2. When 
bones are loaded, the resulting deformation of the bone matrix will drive the thin layer 
of interstitial fluid surrounding the network of osteocytes to flow from regions under high 
pressure to regions under low pressure3,4. This fluid flow is sensed by the osteocytes, which 
subsequently produce signaling molecules, e.g. nitric oxide (NO),5-7 which affect osteoblasts 
and osteoclasts to change their bone remodeling activities leading to changes in bone 
mass8-10. The response of bone cells to mechanical loading is mediated by the cytoskeleton11. 
Moreover cell shape affects the NO response to mechanical loading, i.e. osteocytes with a 
round morphology require lower force stimulation in order to increase NO production than 
osteocytes with a flat morphology12. Thus any factor changing bone cell cytoskeleton or 
shape may affect bone mass.
Fluoride has been used for decades to enhance bone mass in osteoporosis13. Fluoride 
treatment enhances bone mass by stimulation of bone matrix deposition. Serum 
concentrations of fluoride in osteoporotic patients treated with fluoride are only 5-15 
µM14. Fluoride at these concentrations stimulates osteoblast proliferation, differentiation, 
and matrix production15-18. Higher fluoride concentrations increase fracture risk and 
peripheral bone loss in humans, and therefore fluoride has not become routine therapy 
for osteoporosis19. Fluoride is present in varying amounts in air, water, and food, and is an 
essential trace element in the skeletal system and teeth20. Fluoride disrupts the cytoskeleton 
of protozoa21, and F-actin in ameloblasts22. Since fluoride affects bone mass and cytoskeleton, 
we hypothesized that fluoride inhibits the response of mechano-sensitive bone cells to 
mechanical loading. 
The aim of our study was to determine whether fluoride affects the mechano-response 
of bone cells in vitro, and whether this effect is modulated via the actin cytoskeleton. 
Mechano-sensitive MC3T3-E1 osteoblastic cells were treated with or without sodium 
fluoride (NaF) for 24 h. Subsequently cells were subjected to pulsating fluid flow for 30 
min. We used NO production as a parameter for bone cell activation. We also quantified 
cellular F-actin after fluoride treatment. In addition we determined the effect of fluoride on 
osteocyte shape in developing hamster mandibles in vivo. Osteocyte shape was determined 
as parameter for osteocyte mechanosensitivity.
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MATERIALS AND METHODS
MC3T3-E1 osteoblast culture
MC3T3-E1 osteoblast-like cells were cultured in α-MEM medium (Gibco, Paisly, UK) 
supplemented with 100 U/ml penicillin (Sigma-Aldrich, St. Louis, MO, USA), 50 µg/ml 
streptomycin (Sigma-Aldrich), 1.4 mM L-glutamine (Sigma), 9 mM β-glycerophosphate 
(Sigma-Aldrich), 1.9 mM ascorbic acid (vitamin C; Merck, Darmstadt, Germany), and 10% 
fetal bovine serum (FBS; Gibco) at 37ºC, in a humidified atmosphere of 5% CO
2
 in air. Medium 
was exchanged every 3-4 days. Upon confluence, cells were harvested using 0.25% trypsin 
and 0.1% EDTA in phosphate buffered saline (PBS), seeded at 2x105 cells per 75 cm2 culture 
flask (Greiner Bio-One, Kremsmuenster, Austria), and cultured until the cell layer reached 
confluency again. Then cells were used for pulsating fluid flow experiments as described 
below.
Disruption of the actin cytoskeleton. 
Prior to fluid flow stimulation, plated cells were incubated for 1 h in 13 ml of the appropriate 
medium with the total serum content reduced to 2%. Cells were then divided at random 
into two groups: (i) untreated control medium; (ii) actin-disrupted: medium supplemented 
with 1 μM cytochalasin B (Sigma–Aldrich), a toxin that prevents actin polymerization11. We 
observed that this concentration of cytoskeletal-disrupting agent had a significant non-toxic 
effect on cell morphology within 1 h.
Pulsatile fluid flow (PFF)
Two days before PFF treatment, cells were harvested from the culture flasks and seeded 
onto polylysine-coated (50 µg/ml; poly-L-lysine hydrobromide, mol wt 15-30 x 104; Sigma) 
glass slides (size 2.5x6.5 cm) at 2x105 cells/glass slide, and cultured overnight in petridishes 
with 13 ml culture medium containing 10% fetal bovine serum (FBS). Then the culture 
medium was replaced by α-MEM medium containing 0.2% bovine serum albumin (BSA), 
antibiotics, ascorbate (Merck), and either or not 10, 25, or 50 µM NaF. Cells were incubated 
for 24 h, as well as during 30 min of PFF-treatment or static control conditions.
PFF was applied as described earlier.5 Briefly, PFF was generated by pumping 13 ml of 
culture medium through a parallel-plate flow chamber containing MC3T3-E1 osteoblast-
like cells.23 Cells were subjected to a 5 Hz pulse with a mean shear stress of 0.7 Pa, pulse 
amplitude of 0.3 Pa and a peak shear stress rate of 8.4 Pa/s.12 Stationary control cultures 
were kept in a petridish under similar conditions, i.e. at 37ºC in a humidified atmosphere 
of 5% CO
2
 in air. After 5, 10, 15, and 30 min of PFF or static control culture, medium was 
collected and assayed for NO concentrations. 
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Nitric oxide 
NO was measured as nitrite (NO
2
-) accumulation in conditioned medium using Griess reagent 
containing 1% sulfanylamide, 0.1% naphtylethelene-diamine-dihydrochloride, and 2.5 M 
H
3
PO
4
. Serial dilutions of NaNO
2
 in non-conditioned medium were used as a standard curve. 
Absorbance was measured at 540 nm with a microplate reader (BioRad Laboratories Inc.).
DNA content
DNA was isolated directly after PFF from bone cell cultures using TRIzol reagent (Gibco) 
according to the manufacturer’s instructions. DNA in the cell lysate was determined by 
CyQUANT Cell Proliferation assay (Molecular Probes Inc., Eugene, OR, USA).
Staining of filamentous actin (F-actin)
MC3T3-E1 osteoblasts were seeded in 24 well plates at 8.0x103 cells/cm2 (CELLSTAR®, Greiner 
Bio-one, Alphen a/d Rijn, The Netherlands), incubated overnight, followed by an additional 
24 h in a-MEM with 0.2% BSA and with or without 10, 25, or 50 µM NaF. Osteoblasts were 
washed with PBS, fixed with 4.0% formaldehyde, washed again with PBS, and incubated 
with 1:250 dilution of donkey anti-rabbit IgG alexa 488-phalloidin (Invitrogen) for 1 h in PBS. 
F-actin was extracted using methanol and quantified as described24.
Tissue harvesting
A mandibular model of 4-days-old hamsters was used. In short, a single injection of 20 
mg NaF/kg body weight was used to test whether NaF affects osteocyte size (5 hamsters). 
This concentration affects enamel development25. Controls (4 hamsters) received NaCl. 
NaF and NaCl were administered as one single intraperitoneal injection between 10.30-
11.30 AM. Seventy-six hours later, hamsters were sacrificed, mandibles excised, fixed, 
demineralized, dehydrated in ascending ethyl-alcohol series, and embedded in Historesin 
(Leica Microsystems, Mannheim, Germany)25. Sections of 5 µm thickness were cut with 
a microtome in a sagittal plane, mounted on glass slides, and stained with haematoxylin 
according to Mayer, or toluidine blue. Ethical permission was obtained from the VU 
University Amsterdam.
Histology
Histologic and histomophometric analysis was performed using a Leica light microscope with 
electronic stage table (Leica Microsystems, Wetzlar, Germany). Images were captured using 
a Leica digital camera directly connected to a computer. All measurements were done using 
the Leica QWin Pro V 3.5.0 quantitative imaging computer program (Leica Microsystems, 
Heerbrugg, Switzerland). Within each section, three areas of interest were distinguished: 
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1) mesial of the first molar, 2) proximal of the first and second molar, and 3) distal of the 
second molar. In every section these areas of interest were located at 100x magnification, 
and photographed at 400x magnification. Osteocyte morphology was determined by 
measuring length and width. Osteocyte shape is expressed as length-over-width ratio in 
>500 osteocytes per hamster, and the mean shape calculated per animal.  
Statistical analysis
PFF data was obtained from 4 experiments. NO production data are expressed as PFF-over-
static control. All data is expressed as mean±SEM. Data was analysed using Wilcoxon signed-
rank test for paired observations. The unpaired t-test was used for analyzing data from 
individual hamsters. The paired t-test was used to analyze measurements between subjects 
in both control and experimental animals. Differences were considered significant if p<0.05. 
RESULTS
Application of fluid shear stress for 30 min to MC3T3-E1 osteoblasts in the presence or 
absence of NaF did not result in visible changes in bone cell shape or alignment of cells 
in the flow direction (data not shown). NaF treatment did not affect the total amount of 
DNA (control, 1.6x10-7 g; NaF, 1.6x10-7 g). No cells were removed by PFF as assessed by 
microscopic inspection of the cell cultures.
We investigated whether fluoride affects the mechanoresponse of MC3T3-E1 osteoblasts. 
Cells were cultured for 24 h in the presence or absence of NaF, and then treated with or 
without PFF for 30 min. PFF caused a rapid and significant increase in NO production at 5 
min (Fig. 1A). Twenty-four h incubation with 10 µM NaF significantly inhibited PFF-induced 
NO production by 8-fold (Fig. 1A). After 10 min PFF, NaF (10, 25, 50 µM) significantly 
inhibited the PFF-stimulated NO response (Fig. 1B). We also investigated the effect of PFF 
and cytoskeletal disruption by cytochalasin B on the NO response of MC3T3-E1 osteoblasts, 
and found that the PFF-induced increase in NO release at 10 min was inhibited by disrupting 
F-actin (Fig 1C).
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Figure 1. Effect of 24 h NaF treatment (10, 25 or 50 µM) or actin cytoskeleton disruption on PFF-
stimulated NO production by MC3T3-E1 osteoblasts. NaF inhibited the PFF-stimulated NO production 
by MC3T3-E1 osteoblasts, (A) after 5 min PFF, and (B) after 10 min PFF. (C) F-actin cytoskeleton 
disruption inhibited PFF-stimulated NO production at 10 min.11 Values are mean ± SEM of PFF-treated-
over-static control ratios (T/C of 5 independent experiments). Dashed line, T/C=1 (no effect). Stat, 
stationary control culture; PFF, pulsating fluid flow. *Significantly different from 1; #Significantly 
different from untreated.
We then questioned whether the decrease in PFF-stimulated NO production by NaF for 24 
h in osteoblasts is mediated via the actin-cytoskeleton. In untreated cells, actin fibers were 
aligned throughout the whole cell (Fig. 2A). After 24 h NaF (10, 25, 50 µM) treatment, actin 
fibers were at the edge of the cells and less abundant (Fig 2B). NaF (10, 25, 50 µM) also 
reduced the amount of F-actin per well by 3-fold (Fig. 2C). 
We finally tested whether fluoride affects the mechanosensitivity of bone cells in vivo, 
and therefore osteocyte shape was determined in developing hamster mandibles. Three 
areas of interest were defined, i.e. distal, mesial, and proximal area (Fig. 3A), and the 
osteocyte length and width were measured (Fig. 3B). 
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Figure 2. Immunofluorescence analysis and quantification of actin cytoskeleton in MC3T3-E1 
osteoblasts. F-actin (green) was visualized with alexa fluor 488 phalloidin. Representative images of 
(A) control MC3T3-E1 osteoblasts, and (B) F-actin cytoskeleton in MC3T3-E1 osteoblasts after 24 h NaF 
treatment. (C) Quantification of F-actin in MC3T3-E1 osteoblasts. Values are mean ± SEM of 4 cultures 
from 2 independent experiments. *Significant effect of NaF on F-actin, p<0.05.
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Figure 3. Histological section of a hamster first and second molar showing the areas of interest for 
determining osteocyte morphology. (A) Undecalcified, haematoxylin-eosin stained section of a first 
(M1) and second (M2) hamster molar at post-natal day 4 from an animal injected with 20 mg NaF/kg 
body weight, and killed 76 h later, showing the three areas of interest, i.e. proximal area (p), mesial 
area (m), and distal area (d) (magnification, 50x). (B) Higher magnification of (A) stained with toluidine 
blue (magnification, 400x). The square shows a single osteocyte, and lines with double arrow heads 
indicate length and width of the osteocyte. Ocl, osteoclast; Ob, osteoblast; Ocy, osteocyte; B, bone.
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In the distal, mesial, and proximal area, NaF did not affect osteocyte length (Fig. 4A). In the 
proximal area, but not in the other areas, osteocyte width was 9% smaller when treated 
with NaF compared to control (marginally significant, p= 0.07) (Fig. 4B). NaF increased the 
osteocyte length/width ratio by 3% in the mesial area (marginally significant, p = 0.08), but 
not in the other areas (Fig. 4C).
Figure 4. Effect of a single high dose of NaF (20 mg/kg bodyweight) on osteocyte length and width in 
hamster mandibles. (A) Osteocyte length, (B) Osteocyte width, and (C) Osteocyte length/width ratio. 
Values are mean ± SEM of 5 NaF-treated hamsters and 4 controls. *Marginally significant effect of 
fluoride, p=0.07 (Fig. 4B), p=0.08 (Fig. 4C).
DISCUSSION
Mechanosensitive bone cells play a key role in bone remodeling. The cytoskeleton mediates 
the response of bone cells to mechanical loading, and cytoskeletal changes can therefore 
affect bone remodeling11. Since the bone anabolic agent fluoride affects the cytoskeleton, we 
hypothesized that 1) fluoride reduces the mechano-response of osteoblasts to mechanical 
loading by pulsating fluid flow in vitro, and that this is modulated via the actin-cytoskeleton, 
and 2) that fluoride affects osteocyte mechanosensitivity, the bone mechanosensors par 
excellance, in hamster mandibles in vivo. In this report, we present compelling evidence 
that treatment with fluoride at physiological concentrations in vitro inhibits PFF-stimulated 
NO production by MC3T3-E1 osteoblasts. The same micromolar concentrations of fluoride 
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affected the arrangement and amount of F-actin in these cells. Inhibition of the NO response 
to PFF was also observed after cytoskeletal disruption by cytochalasin B. The NO production 
(PFF/Stat) in the control (0 micro M) is about 8 in Fig. 1A and Fig 1B, while in Fig. 1C, NO 
production (PFF/Stat) in “untreated” is about 1.8. We adopted Figure 1C from McGarry 
et al.11 In these experiments, a low percentage of serum (2%) was present in the culture 
medium during the mechanical loading (PFF) experiments. In our experiments (Figure 1A 
and 1B) 0.3% BSA was added to the medium rather than serum. Serum in culture medium 
will not alter the activation of biological pathways by PFF in osteoblasts, but serum does 
alter the magnitude of the response of osteoblasts to pulsating fluid flow (unpublished 
observations within our laboratory). In addition we found that fluoride marginally changes 
osteocyte shape in the mesial region in hamster mandibles in vivo. Fluoride treatment 
resulted in more elongated and smaller osteocytes. Why this occurs only in the mesial 
region is not clear. Our results suggest that fluoride inhibits the mechano-response of bone 
cells by cytoskeletal changes.
We applied mechanical loading by PFF of 0.7±0.3 Pa at 5 Hz. This stimulus is based on the 
currently available knowledge on physiological bone loading stimuli. The frequency spectra 
after loading of the hip bone in living humans have been calculated to range between 1 and 
3 Hz for walking cycles and reaching 8 to 9 Hz for running cycles26. The fluid shear stress 
amplitude around osteocytes, resulting from daily mechanical loads, have been determined 
theoretically to range from 0.8 to 3 Pa due to physiological strains in humans23. Although the 
accuracy of these calculations are currently under debate, it is noteworthy that bone cells in 
vitro seem to be highly sensitive to shear stress in the order of this magnitude. 
We showed that fluoride affects the arrangement and amount of F-actin in MC3T3-E1 
osteoblasts. These findings agree with a study showing that fluoride affects the activity of 
several g-proteins involved in the microtubular system and other cytoskeletal compounds 
in protozoa21. Since the response of bone cells to mechanical loading is mediated by 
the cytoskeleton11, our findings suggest that fluoride affects the mechano-response of 
osteoblasts via modulation of cellular F-actin. 
Another explanation for the fluoride-induced decrease in NO response to mechanical 
loading by PFF in MC3T3-E1 osteoblasts could be increased activity of superoxide dismutase 
(SOD). Fluoride induces oxidative damage in mouse osteoblasts27. Oxidative damage in 
cells by reactive oxygen species is controlled by increasing SOD activity. SOD scavenges free 
radicals such as NO, and turns these into oxygen and hydrogen peroxide28. It is possible 
that in the presence of NaF osteoblasts experienced oxidative stress and did respond with 
increased SOD activity, thereby eliminating the NO produced as a result of PFF treatment. 
The effect of fluoride on the arrangement and amount of F-actin in osteoblasts in vitro 
is in agreement with our in vivo observations. Fluoride did not affect osteocyte length in the 
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mesial, distal, and proximal regions of the hamster mandible, but it decreased osteocyte 
width in the proximal region and increased osteocyte length-over-width ratio in the mesial 
region, indicating that a single high dose of NaF in hamster pups resulted in formation of 
more elongated and smaller osteocytes in the growing mandible. Bone around developing 
molar teeth has a high turnover, and osteoblasts briefly exposed to fluoride turn into 
osteocytes within three days. Our results suggest that fluoride inhibits the mechanoresponse 
via cytoskeletal changes resulting in changes in osteocyte morphology, since differences in 
osteocyte morphology indicate differences in mechanosensitivity12.
The decreased NO response to mechanical loading by PFF, in combination with the 
affected cytoskeleton and the smaller osteocytes in vivo, as a result of fluoride treatment 
suggest that bone cell mechanosensitivity is affected by fluoride. We conclude that fluoride 
causes rearrangement of the actin cytoskeleton, thereby changing osteocyte shape and 
mechanical loading-induced NO production. The known anabolic effect of fluoride on bone 
mass is therefore likely mediated by other factors than changed bone cell mechanosensitivity.
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ABSTRACT
Osteocytes orchestrate the adaptation of bone mass and structure to mechanical stimulation. 
The inflammatory cytokine interleukin-1b (IL-1b) reduces the response of osteocytes to 
mechanical stimuli. Since phenolic dietary compounds counteract the effects of inflammatory 
cytokines, we investigated whether the phenolic compound oleuropein affects the response 
of IL-1b–treated osteocytes to mechanical stimulation. MLO-Y4 osteocytes were treated 
with or without 10-8 M oleuropein and/or 1 ng/ml IL-1β. Human osteoblasts obtained from 
long bones of osteoporotic patients and controls, and MLO-Y4 osteocytes were subjected 
for 1 h to pulsating fluid flow (PFF: 0.7±0.3 Pa, 5 Hz). The response to PFF was assessed by 
quantification of nitric oxide (NO) production and measuring cyclooxygenase-2 (COX-2) gene 
expression. In addition, effects of oleuropein and IL-1β on the cytoskeleton were assessed 
by quantification of filamentous actin. PFF stimulated NO production within 5 min in MLO-Y4 
osteocytes, and in human control osteoblasts. The NO response to PFF was lower in human 
osteoblasts from osteoporotic patients than in control bone cells. In MLO-Y4 osteocytes, 
IL-1β reduced the PFF-stimulated NO production by 1-1.5-fold. This inhibition could not be 
reversed by oleuropein treatment. Furthermore IL-1b decreased F-actin content and COX-2 
gene expression in response to PFF. Oleuropein prevented the effect of IL-1b on PFF-induced 
COX-2 gene expression but not on F-actin content. Our results show that the effect of IL-
1b on the mechano-response of osteocytes might be mediated by changes in F-actin, and 
that oleuropein prevents the IL-1b–modulated COX-2 gene expression in response to PFF. 
Therefore we conclude that oleuropein may reduce the inflammation-induced bone loss 
in vivo by reducing the inhibitory effect of IL-1b on PFF-stimulated COX-2 gene expression. 
Key words: osteocytes, mechanical loading, oleuropein, NO, COX-2, IL-1β, cytokines.
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INTRODUCTION
Bone is a living tissue, which adapts its mass and structure to the demands of mechanical 
loading.1,2. This adaptation to the mechanical demands is a cellular process, needing a 
biological system to function. In this active process of mechanical adaptation, the sensing of 
the mechanical signals occurs by the osteocytes3-5, the professional mechanosensory cells 
within the bone. Osteocytes are distributed in the bone matrix and connected to each other 
via long slender cell processes that run through the canaliculi6, forming a unique network 
that facilitates contact with cells on the bone surface6. Slight deformation of bone occurs 
as a result of mechanical loading, causing a flow of interstitial fluid through this lacuno-
canalicular network7, which result in a shear stress on the osteocyte cell membrane5,7. 
As a response to this shear stress, osteocytes produce signaling molecules, such as nitric 
oxide (NO), which is essential for adaptive bone formation8, and prostaglandin E
2
, which 
are early components of the bone cells’ response to mechanical strain9. It is likely that the 
cytoskeleton determines the manner by which osteocytes respond to a fluid shear stress10. 
The cytoskeleton determines both cell stiffness and cell shape. Moreover the NO response 
of osteocytes to mechanical loading is affected by the cell shape, i.e. osteocytes with a 
round morphology require lower force stimulation in order to increase NO production than 
osteocytes with a flat morphology11. 
Another important parameter in the process of bone formation after mechanical loading 
is cyclooxygenase (COX). A 15 min treatment of osteocytes with fluid shear stress already 
leads to a three-fold increase of COX-2 mRNA expression12. Moreover, COX-2 expression is a 
crucial step in the induction of bone formation by mechanical stimuli in vivo9.
Bone mass peaks between the age of 20 to 30 years, after which it declines. A prompt 
decline in estrogen levels after menopause in women plays an important role in the etiology 
of osteoporosis, which occurs if bone resorption exceeds bone formation13,14. The decrease 
in estrogen levels after menopause is accompanied by a chronic inflammatory status15, and 
the production of cytokines16. The cytokines IL-1β, TNF-a, and IL-6 are known to affect bone 
turnover by increasing bone resorption17, and IL-1β and TNF-a are also known to reduce 
bone formation. Although the pathogenesis of post-menopausal osteoporosis is not fully 
understood, there is increasing evidence that inflammation contributes to osteoporosis by 
causing increased osteoclast activity13,16,18. 
Phenolic compounds have been shown to decrease the production of inflammatory 
cytokines in macrophage cell lines17. Oleuropein is the most representative catecholic 
component of olives and their derivates in olive oil19. In Mediterranean countries the average 
intake of oleuropein is approximately 25 mg/day20. In these countries, a lower incidence 
of cardiovascular disease has been observed19. Since the development of cardiovascular 
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disease, e.g. atherosclerosis, includes a strong inflammatory component21, these findings 
suggest that phenolic compounds reduce the negative effects of inflammatory cytokines on 
cells. Oleuropein also inhibits cytokine-mediated bone loss in a postmenopausal bone model 
of ovariectomized rats22. Oleuropein stimulates the production of NO by macrophages via a 
direct effect on the inducible form of nitric oxide synthase24. In addition, oleuropein induces 
cell rounding in different cell lines in vitro and in mice tumor cells in vivo. The effect of 
oleuropein on the shape of tumor cells was explained by an immediate effect on the actin 
cytoskeleton25. Therefore oleuropein could potentially affect the response of bone cells to 
mechanical stimulation via an effect on the cytoskeleton. 
Both oleuropein and mechanical loading are able to increase bone mass via the 
production of signaling molecules involved in bone formation, but it is unknown whether 
the combination of mechanical loading and oleuropein affects COX-2 gene expression by 
osteocytes. We investigated whether oleuropein affects the inhibitory effect of IL-1b on 
the mechanoresponse of osteocytes in vitro by measuring COX-2 gene expression and NO 
production in osteocytes subjected to mechanical loading. Since oleuropein likely affects 
f-actin we aimed to determine whether oleuropein modulates the combined effect of IL-1b 
and mechanical stimulation on the mechanoresponse of osteocytes, and if this potential 
modulation was mediated by the f-actin cytoskeleton. MLO-Y4 osteocytes were treated 
with or without oleuropein and/or IL-1β, and human osteoblastic cells obtained from 
long bones were subjected to 1 h of pulsating fluid flow (PFF). The bone cell response to 
mechanical loading was assessed by quantifying NO production, and measuring COX-2 
gene expression. Finally we tested whether oleuropein did affect the f-actin cytoskeleton of 
MLO-Y4 osteocytes.
MATERIALS AND METHODS
Human osteoblast isolation and culture
For the isolation of human osteoblasts, trabecular bone samples (surgical waste) were 
obtained from 6 female osteoporotic patients. Trabecular bone samples were obtained from 
the proximal femur shaft after hip replacement surgery for cox-arthrosis or after surgery for 
subcapitalhip fracture. The protocol was approved by the Ethical Review Board of the VU 
University Medical Center, Amsterdam, The Netherlands, and all subjects gave informed 
consent.
Human trabecular bone biopsies were placed in sterile phosphate buffered saline (PBS), 
chopped into small fragments, and washed extensively with PBS. To obtain bone cells, 
bone fragments were cultured in Dulbecco’s minimal essential medium (DMEM; Gibco, 
Grand Island, NY) supplemented with 100 U/ml penicillin (Sigma, St Louis, MO), 50 µg/ml 
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streptomycin sulfate (Gibco), 50 µg/ml gentamicin (Gibco), 1.25 µg/ml fungi-zone (Gibco), 
100 µg/ml ascorbate (Merck, Darmstadt, Germany), and 10% fetal bovine serum (FBS). After 
reaching subconfluency, human osteoblasts were trypsinized with 0.25% trypsin (Difco, 
Detroit, MI), and replated at 5 x 103 cells / 75 cm2 flask until subconfluency was reached 
again. All cells used were from passage 3 or lower. For PFF experiments, human osteoblasts 
were harvested and seeded at 5 x 105 cells/cm2 of polylysine-coated (50 µg/ml; poly-L-lysine 
hydrobromide, mol wt 15-30 x 104; Sigma) glass slides (15 cm2), and incubated overnight to 
promote cell attachment. 
Osteocyte culture
MLO-Y4 osteocytes, a cell line derived from mouse long bones25, were cultured in α-minimum 
essential medium (αMEM) supplemented with 5% FBS (Gibco), 5% calf serum (Gibco), 50 
µg/ml gentamicin (Gibco), 1.25 µg/ml Fungizone (Gibco), 60 µg/ml penicillin (Sigma), and 
50 µg/ml streptomycin (Sigma) at 37°C and 5% CO2 in air in a humidified incubator. Cells 
were harvested between passages 30 and 35 using 0.25% trypsin (Difco) and 0.1% EDTA 
(Sigma) in PBS, and seeded at 2 x 104 cells/cm2 on poly-L-lysine hydrobromide–coated glass 
slides (total area 15 cm2). Cells were incubated overnight in medium with serum to allow cell 
adherence to the glass surface, followed by 24 h pre-incubation before PFF treatment with 
10-7, 10-8, or 10-9 M oleuropein (Frutarom Netherlands BV, Veenendaal, The Netherlands) 
and/or 1 ng/ml IL-1β (Sigma). The concentrations of IL-1β used for this study were based on 
the concentrations found in plasma of patients with rheumatoid arthritis26.
Pulsating fluid flow
PFF was applied for 1 h as described earlier4. Briefly, PFF was generated by pumping 13 ml of 
aMEM medium without or with 10-7, 10-8 or 10-9 M oleuropein and/or 1 ng/ml IL-1β through 
a parallel-plate flow chamber containing the MLO-Y4 osteocytes or by pumping DMEM 
medium through a parallel-plate flow chamber containing human osteoblasts. Cells were 
subjected for 1 h to a 5 Hz pulse with a mean shear stress of 0.7 Pa, and a pulse amplitude 
of 0.3 Pa. Stationary control cultures were kept in a petridish under similar conditions as the 
experimental cultures, i.e. at 37˚C in a humidified atmosphere of 5% CO
2
 in air. After 5 min 
of PFF or static control culture, medium was collected and assayed for NO concentrations. 
Nitric oxide
NO was measured as nitrite (NO
2
-) accumulation in medium using Griess reagent containing 
1% sulfanylamide, 0.1% naphtylethelene-diamine-dihydrochloride, and 2.5 M H
3
PO
4
. Serial 
dilutions of NaNO
2
 in non-conditioned medium were used as standard curve. Absorbance 
was measured at 540 nm with a microplate reader (BioRad Laboratories Inc.).
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Total RNA, and cDNA synthesis
RNA was isolated from MLO-Y4 cell cultures after 1 h of PFF or static culture, using 
TRIzol reagent (Gibco) according to the manufacturer’s instructions. The RNA content 
was determined by measuring the absorbance in water at 260 nm using an Ultrospec III 
spectrophotometer (Amersham). cDNA synthesis was performed using 1 μg total RNA in a 
20 ml reaction mix consisting of 5 units Transcriptor Reverse Transcriptase (Roche Diagnostics), 
0.08 A
260
 units random primers (Roche Diagnostics), 1 mM of each dNTP (Invitrogen), and 1x 
concentrated Transcriptor RT reaction buffer (Roche Diagnostics). 
Analysis of gene expression
MLO-Y4 gene expression of COX-2 was analyzed using Taqman® Gene expression assays 
(Inventoried Taqman® Gene expression assays, Applied Biosystems) in an ABI Prism 7700 
sequence detector (Applied Biosystems). Gene expression values were normalized for 
mouse GAPDH (Inventoried Taqman® Gene expression assays, Applied Biosystems).
Staining of filamentous actin (F-actin)
MLO-Y4 osteocytes were seeded in 24 well plates at 8 x 103 cells/cm2 (CellStar®, Greiner 
Bio-one, Alphen a/d Rijn, The Netherlands), incubated overnight, followed by an additional 
24 h incubation with or without 10-8 M oleuropein and/or 1 ng/ml IL-1β. Osteocytes were 
washed with PBS, fixated with 4% formaldehyde, washed again with PBS, and incubated 
with 1:250 dilution of donkey anti-rabbit IgG alexa 488-phalloidin (Invitrogen) for 1 h in PBS. 
F-actin was extracted using methanol and quantified as described by Pritchard and Guilak 
(2006)27.
Statistical analysis
PFF data was obtained from 3 or 4 separate experiments. NO production was expressed as 
PFF-over-static control values. All data is expressed as mean ± SEM. NO production data was 
analyzed using Wilcoxon signed-rank test for paired observations. Mann-Whitney U tests or 
Student’s unpaired 2-tailed t-tests were used to test the effect of oleuropein and IL-1b. A 
p<0.05 was considered significant.
RESULTS
Human primary bone cells obtained from patients with osteoporosis and from non-
osteoporotic patients were submitted to 1 h of pulsating fluid flow (PFF; Figure 1A). No cells 
were removed by the fluid flow treatment, as assessed by quantification of the DNA content 
(data not shown). NO release was measured after 5 min of PFF treatment as a parameter 
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for bone cell responsiveness to mechanical loading. Five minutes of PFF-treatment tended 
to increase the NO production by 3-fold (p=0.08; Figure 1A) in cells isolated from non-
osteoporotic patients. In cells from osteoporotic patients, 5 min PFF-treatment increased 
NO production by 2-fold (p=0.01; Figure 1A). The absolute NO production in response to 
mechanical loading was higher in cells from non-osteoporotic patients than in cells from 
osteoporotic patients (p=0.04; Figure 1A). To show that primary human bone cells and 
MLO-Y4 osteocytes respond in a similar manner to PFF-treatment, we subjected MLO-Y4 
osteocytes to PFF and measured the NO response (Figure 1B). We found that PFF increased 
NO production by 10-fold (p=0.01; Figure 1B). Addition of 1 nM IL-1ß abolished the 
upregulation of NO production in response to PFF (Figure 1B). Twenty-four h incubation 
with oleuropein did not counteract this inhibitory effect of IL-1β on NO production after 
mechanical loading by MLO-Y4 osteocytes (Figure 1C). Oleuropein alone did not affect the 
PFF-stimulated NO production (data not shown). 
Figure 1. Effect of PFF on NO production by human primary bone cells and MLO-Y4 osteocytes. PFF-
stimulated NO production after 5 min in (A) human primary bone cells from healthy subjects and 
osteoporotic patients, (B) MLO-Y4 osteocytes, and (C) MLO-Y4 osteocytes treated with IL-1β and 
oleuropein. Values are mean ± SEM of absolute NO values obtained from 5 independent experiments. 
Stat, stationary control culture; PFF, pulsating fluid flow; control, non-osteoporotic subjects; OP 
patients, osteoporotic patients. *Significant effect of PFF or oleuropein, p<0.05.
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To establish whether IL-1β and oleuropein alter PFF-induced gene expression in MLO-Y4 
osteocytes, basal COX-2 gene expression as well as COX-2 gene expression after PFF 
treatment were determined. PFF increased COX-2 gene expression by 2-fold. Twenty four 
h incubation with IL-1β decreased COX-2 gene expression in PFF-treated osteocytes by 2.3-
fold (p=0.02; Figure 2). Twenty-four h incubation with oleuropein abolished the inhibitory 
effect of IL-1b on PFF-induced COX-2 gene expression (p=0.02; Figure 2). 
Figure 2. Effect of IL-1β and oleuropein on PFF-induced gene expression in MLO-Y4 osteocytes. Twenty-
four h incubation with IL-1β decreased COX-2 gene expression. Values are mean ± SEM of relative gene 
expression obtained from 6 independent experiments. Stat, stationary control culture; PFF, pulsating 
fluid flow; OP, oleuropein; IL-1β, interleukin-1β. *Significantt effect of PFF, oleuropein or IL-1β, p<0.05.
We then investigated whether IL-1β and oleuropein affect the actin-cytoskeleton. Oleuropein 
at 10-8 M did not change the amount of F-actin per well (Figure 3). IL-1β decreased the 
amount of F-actin by ~1.2 fold (p=0.01), but addition of oleuropein could not prevent this 
IL-1β-induced decrease in f-actin fiber content (p=0.07). These data show that IL-1β affected 
the F-actin cytoskeleton, but that addition of oleuropein could not prevent this drop in 
F-actin content.
Figure 3. Quantification of F-actin in MLO-Y4 osteocytes. Values are mean ± SEM of 4 cultures from 5 
independent experiments. *Significant effect of oleuropein, p<0.05.
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DISCUSSION
Osteocytes regulate bone mass by dictating the balance between bone formation and 
resorption in response to mechanical loading1. Therefore, any factor affecting this osteocyte 
response to mechanical loading, in essence, is able to alter bone mass. One factor known 
to affect the response of bone cells to mechanical stimuli is IL-1β. Since oleuropein may 
reverse the effects of cytokines on bone cells, we hypothesized that the phenolic compound 
oleuropein counteracts the modulatory effects of IL-1β on the response of osteocytes 
to mechanical stimulation. We found that primary bone cells derived from osteoporotic 
patients produce less NO in response to PFF compared to bone cells from non-osteoporotic 
patients. We also found that IL-1β inhibits the PFF-induced up-regulation of NO production 
by MLO-Y4 osteocytes. These results are in accordance with findings by others28. Our 
findings show that the inflammatory cytokine IL-1β, which plays a role in the development 
of osteoporosis29, modulates the mechanoresponse of bone cells to PFF. 
The frequency spectra after hip loading in vivo in humans have been calculated30, showing 
a range between 1-3 Hz (walking) up to 9 Hz (running). Daily mechanical loading-induced 
fluid shear stress in vivo has been predicted to range from 0.8-3 Pa30. Bone cells in vitro seem 
to be highly sensitive to shear stress of this order of magnitude. The stimulus of 0.7 ± 0.3 
Pa at 5 Hz we applied during PFF-treatment is therefore based on known physiologic bone-
loading stimuli. We showed that both primary human bone cells and MLO-Y4 osteocytes 
respond similarly to PFF in terms of increased NO production, indicating a physiological 
response of these bone cells to mechanical loading.
Oleuropein has been reported to increase NO production from LPS-challenged mouse 
macrophages via increased iNOS gene expression24. However oleuropein is also able to 
scavenge nitric oxide31. The scavenging capacity is explained by the fact that oleuropein is 
a catecholic compound. In catechols, each OH-group has a high electron-donating effect 
on the other OH-group. Weakening of the OH-bond by this electron donation facilitates 
transfer of a hydrogen atom to OH, converting the OH to water32,33. Oleuropein has also 
been shown to protect against bone loss in a rat model of inflammation-induced bone loss, 
likely via modulation of cytokines22. We showed that oleuropein did not counteract the 
inhibitory effects of IL-1β on PFF-stimulated NO production. These findings are not in line 
with the findings in the rat model of inflammation-induced bone loss, since oleuropein did 
not modulate the effects of IL-1β in our model. 
Various studies have shown a key role for prostaglandin signaling in mechanotransduction. 
Exposure to mechanical stimulation rapidly increases COX-2 expression in osteoblasts and 
osteocytes34-36. We found that IL-1β decreased the PFF-induced COX-2 gene expression. 
This is in contrast with findings by others that cytokine treatment enhances COX-2 gene 
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expression37. However Sugiyama et al. (2012) recently reported that inhibition of COX-2 
expression in mice does not affect the trabecular or cortical bone response to mechanical 
stimuli. Therefore we speculate that the IL-1β-induced decrease of PFF-stimulated COX-2 
expression does impair the skeletal response to daily loading in women38. Bakker et al.28 
reported that 24 h of IL-1β treatment dose-dependently increased caspase 3/7 activity 
which indicates increased osteocyte apoptosis28. In our study we also treated the cells for 24 
h with IL-1β to mimic inflammation in vivo, which might have caused osteocyte apoptosis, 
and decreased COX-2 gene expression. Polyphenols in olive oil rapidly inhibit p38 and CREB 
phosphorylation, which leads to downstream reduction in COX-2 expression39. Oleuropein 
counteracted the inhibitory effect of IL-1β on PFF-stimulated COX-2 gene expression. 
Since the response of osteocytes to PFF depends on an intact cytoskeleton, we tested 
the effect of oleuropein on the F-actin content of osteocytes treated with or without IL-1β. 
Oleuropein alone did not affect the F-actin content in MLO-Y4 osteocytes. IL-1β decreased 
the amount of F-actin, while addition of oleuropein was not able to counteract the IL-1β-
induced decrease in F-actin content. Others have found that oleuropein directly disrupts 
actin filaments in a cell-free assay, while we tested the effect of oleuropein on F-actin in 
intact cells. This might explain the unaffected f-actin content in our experiments. The nature 
and kinetics of the disruption is currently under investigation. 
One must be cautious when interpreting these data, because many variables are 
involved in a chronic inflammatory response15,16. The absence of an effect of oleuropein on 
the decrease in F-actin content caused by IL-1β does not necessarily imply that oleuropein is 
not counteracting the negative effects of inflammation of bone mass, since in this study we 
focused on the effect of IL-1β , at one time point only. It is possible that oleuropein has an 
effect on TNF-a induced bone loss, or bone loss induced by other cytokines.
We conclude that oleuropein did not affect the IL-1b-modulation of mechanical loading-
induced NO production in osteocytes, but it did counteract the negative effect of IL-1b 
on PFF-induced COX-2 expression. This suggests that oleuropein and IL-1b interact in the 
process of mechanotransduction via an effect on COX-2 expression. 
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ABSTRACT
In response to mechanical stimuli mechanosensitive bone cells produce signaling 
molecules such as nitric oxide (NO) resulting in the adaptation of bone mass and structure 
to the demands of mechanical loading. A disturbed response of bone cells to mechanical 
loading can lead to osteoporosis and increased fracture risk. Since fracture prevention is 
needed the search for new therapeutic agents is ongoing. An interesting agent might be 
glucose-dependent insulinotropic peptide (GIP) that affects bone mass and bone micro-
architecture, but its mechanism of action is still unclear. We aimed to determine whether 
GIP modulates the response of mechanosensitive osteoblasts to mechanical stimulation. 
MC3T3-E1 osteoblasts were treated for 2 h with or without 0.05, 0.2, or 0.5 nM GIP, and 
subjected for 1 h to pulsating fluid flow (PFF: 0.7±0.3 Pa, 5 Hz) or static control culture. 
The osteoblast response to PFF was assessed by quantifying NO-production. In the absence 
of GIP, PFF stimulated NO production by osteoblasts within 5 min. Treatment with GIP at 
all concentrations tested decreased the PFF-stimulated NO production by 1.5 to 5.5-fold, 
demonstrating that GIP affects the mechano-response of osteoblasts. Since GIP can be 
readily found in the circulation, it might reach the bone cells within the highly vascularized 
bones. An altered responsiveness of bone cells to mechanical stimuli in vivo likely leads to a 
change in the balance between bone formation and resorption, thereby altering bone mass 
and structure. We conclude that biological pathways affecting GIP might be interesting new 
potential targets for treatment of bone diseases such as osteoporosis. 
Key words: osteoblasts, mechanical stimulation, PFF, GIP, nitric oxide.
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INTRODUCTION
The lack of mechanical stimuli results in a rapid loss of bone mass1,2 since bone adapts its 
mass and structure to the demands of mechanical usage3,4. In this process of mechanical 
adaptation of bone, the mechanical signals are received by the osteocytes within the 
bone matrix5-7. Osteocytes are the most prevalent bone cells; there are approximately 20 
times more osteocytes than mature osteoblasts and osteoclasts combined. With their cell 
bodies located in lacunae and their long interconnected cell processes positioned in the 
canaliculi, osteocytes are uniquely positioned within the bone matrix8. Upon mechanical 
use, a slight deformation of bone occurs as a result of mechanical loading, which drives a 
flow of interstitial fluid through the canaliculi9, resulting in shear stress on the osteocyte cell 
membrane7,11. In response to this fluid flow the osteocytes produce signaling molecules, 
such as nitric oxide (NO), which is essential for adaptive bone formation12. Osteocytes are 
terminally differentiated cells of the osteoblast lineage. It has been shown that osteoblasts 
also produce signaling molecules in response to mechanical stimuli, although osteoblasts 
are less sensitive to mechanical stimuli in the form of fluid flow than osteocytes6.
Skeletal abnormalities such as osteoporosis can be seen as failure of the skeleton to 
maintain bone mass to withstand fracture13. Osteoporosis is primarily present in the 
elderly, and it is expected that the number of osteoporosis-related fractures will increase 
substantially in the near future14. Osteoporosis-related fractures lead to diminished quality 
of life, disability, discomfort, and sometimes even death. Thus, prevention of bone fractures 
is urgently required14, and the search for new therapeutic targets is ongoing.
Food intake affects bone turnover 15,16. This occurs via the well-known pathways involving 
vitamin D or parathyroid hormone17, but there are indications that other mechanisms 
are also involved in the interaction between nutrition and bone homeostasis. Recently it 
has been suggested that hormones produced in the gastro-intestinal tract might play an 
essential role in bone homeostasis18. Glucose-dependent insulinotropic peptide (GIP) is a 
gut factor released by entero-endocrine K-cells in the duodenum and jejunum in response 
to carbohydrate and fat ingestion19. GIP increases collagen type I expression and alkaline 
phosphatase activity in various osteosarcoma cell lines20, and GIP protects osteoblasts 
from going into apoptosis21. The role of GIP in the modulation of bone turnover has been 
studied using knockout mice models22. GIP-receptor knockout mice show a phenotype of 
decreased bone formation, smaller bones, decreased bone mass, and alterations in bone 
microarchitecture and biomechanical properties23. On the other hand, transgenic mice 
overexpressing GIP show increased markers of bone formation, and decreased markers of 
bone resorption23. Consistent with these findings is the observation that GIP overexpressing 
mice show increased bone mass24. These studies show that GIP can positively affect bone 
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formation, resulting in higher bone mass. In view of GIP’s role in nutrient absorption, 
this published data suggests that GIP might play a role in linking nutrient ingestion to 
bone formation. Although there is a proven connection between GIP and mechanical 
stimulation25, to date this connection has not been observed in bone. Therefore the aim 
of this study was to determine whether GIP modulates the response of mechanosensitive 
osteoblasts to mechanical stimulation. We subjected MC3T3-E1 osteoblasts treated with or 
without GIP (0.05, 0.2, or 0.5 nM) to mechanical loading by a pulsating fluid flow (PFF). The 
osteoblast response to mechanical loading was assessed by quantification of NO production. 
MATERIALS AND METHODS
Osteoblast culture
MC3T3-E1 osteoblast-like cells were cultured in α-MEM medium (Gibco, Paisly, UK) 
supplemented with 100 U/ml penicillin (Sigma-Aldrich, St. Louis, MO, USA), 50 μg/ml 
streptomycin (Sigma-Aldrich), 1.4 mM l-glutamine (Sigma), 9 mM β-glycerophosphate 
(Sigma-Aldrich), 1.9 mM ascorbic acid (vitamin C; Merck, Darmstadt, Germany), and 10% 
fetal bovine serum (FBS; Gibco) at 37°C, in a humidified atmosphere of 5% CO
2
 in air. Medium 
was changed every 3-4 days. Upon confluence, cells were harvested using 0.25% trypsin and 
0.1% EDTA in phosphate buffered saline (PBS), seeded at 2 × 105 cells per 75 cm2 culture 
flask (Greiner Bio-One, Kremsmuenster, Austria), and cultured until the cell layer reached 
confluency again. Then cells were used for pulsating fluid flow experiments as described 
below. 
Pulsating fluid flow
Two days before pulsating fluid flow (PFF) treatment, cells were harvested from the culture 
flasks and seeded onto polylysine-coated (50 μg/ml; poly-l-lysine hydrobromide, mol wt 
15-30 × 104; Sigma) glass slides (size 2.5 × 6.5 cm) at 2 × 105 cells/glass slide, and cultured 
overnight in petri dishes with 13 ml culture medium containing 10% FBS. Then the culture 
medium was replaced by α-MEM medium containing 0.2% bovine serum albumin (BSA), 
antibiotics, ascorbate (Merck), and with or without 0.05, 0.2 or 0.5 nM GIP (Sigma-Aldrich). 
Cells were incubated with GIP for 2 h or 24 h before subjecting the cells to PFF or static 
control culture in the presence of GIP. 
PFF was applied as described earlier26. Briefly, PFF was generated by pumping 13 ml of 
culture medium through a parallel-plate flow chamber containing the MC3T3-E1 osteoblast-
like cells. Cells were subjected to a 5 Hz pulse with a mean shear stress of 0.7 Pa, pulse 
amplitude of 0.3 Pa, and a peak shear stress rate of 8.4 Pa/s27. Stationary control cultures 
were kept in a Petri dish under similar conditions, i.e. at 37°C in a humidified atmosphere 
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of 5% CO
2
 in air. After 5, 10, 15, and 30 min of PFF or static control culture, medium was 
collected and assayed for NO concentrations. 
Nitric oxide
NO was measured as nitrite (NO
2
-) accumulation in the medium using Griess reagent 
containing 1% sulfanylamide, 0.1% naphtylethelene-diamine-dihydrochloride, and 2.5 M 
H
3
PO
4
. Serial dilutions of NaNO
2
 in non-conditioned medium were used as standard curve. 
Absorbance was measured at 540 nm with a microplate reader (BioRad Laboratories Inc.).
Statistical analysis
PFF data was obtained from 5 or more separate experiments. NO production was expressed 
as PFF-over-static control values. All data is expressed as mean ± SEM. NO production data 
was analyzed using Wilcoxon signed-rank test for paired observations. A p value less than 
0.05 was considered significant.
RESULTS
Application of PFF for 30 minutes to MC3T3-E1 osteoblasts did not result in visible changes 
in cell shape or alignment of the cells in the direction of the flow. No cells were removed by 
application of the fluid shear stress regime, as assessed by visually inspecting the cultures 
before and after PFF treatment.
In the absence of GIP, bone cells kept under stationary control conditions produced 
small amounts of NO (1.22±0.18 nMole) during the 30 min of the experiment (Fig. 1A). PFF 
treatment rapidly stimulated NO production by MC3T3-E1 osteoblasts (Fig. 1A). Incubation 
with GIP (0.05-0.5 nM) for 2 h significantly decreased the amount of PFF-stimulated NO 
production by MC3T3-E1 osteoblasts by 1.5-5.5 fold compared to cells that were not treated 
with GIP (Fig. 1B). Twenty four h of GIP treatment had no effect on the PFF-stimulated NO 
production by MC3T3-E1 osteoblasts (data not shown).
To exclude the effects of basal variation in NO production, the PFF-treated-over-static 
control (T/C) ratios were calculated for each separate experiment. In the absence of GIP, 
PFF stimulated NO production by 5 to 14-fold (Fig. 2A). Incubation for 2 h with 0.05 nM GIP 
inhibited the magnitude of the NO response by MC3T3-E1 osteoblasts already at 5 min (Fig. 
2B). This inhibitory effect of GIP on the magnitude of the NO response became significant 
for all tested concentrations of GIP after 30 min of PFF treatment. 
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Figure 1. Effect of PFF on NO production by MC3T3-E1 osteoblasts. (A) PFF-stimulated NO production, 
and (B) GIP significantly inhibited the PFF-induced NO production by MC3T3-E1 osteoblasts during 30 
min of PFF-treatment. Values are mean ± SEM of absolute NO values (5 independent experiments). 
Stat, stationary control culture; PFF, pulsating fluid flow; *Significant effect of PFF or GIP, p<0.05.
Figure 2. Mechanical loading by pulsating fluid flow increases NO production of MC3T3-E1 osteoblasts. 
A) GIP diminished the PFF stimulated NO-production. B) GIP significantly inhibited the PFF-induced NO 
production in MC3T3-E1 osteoblasts during 30 min of PFF-treatment. Values are mean ± SEM of PFF-
treated over static-control ratios (T/C, of independent experiments). Dashed line, T/C=1 (no effect). 
GIP, glucose-dependent insulinotropic peptide. *Significant effect of GIP, p<0.05.
DISCUSSION
It is well documented that transduction of a mechanical stimulus by bone cells leads to NO 
production, an essential regulator of loading-induced bone formation1,26,28. Gut-hormones 
like GIP have also been suggested to be involved in bone metabolism29,30. The role of GIP 
in bone turnover has been investigated using transgenic mice models23,24. From these 
studies it can be deduced that GIP affects bone strength, likely due to alterations in skeletal 
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micro-architecture and biomechanical properties, and increased bone mass23. Although the 
number of studies on the role of GIP in bone biology is increasing, we were the first to test 
whether GIP has a direct effect on the response of bone cells to a mechanical stimulus. 
We found that GIP (0.05-0.5nM) reduces the magnitude of the NO response of osteoblasts 
to mechanical stimulation by PFF. These results are in accordance with the finding that 
GIP reduces the activity of nitric oxide synthase (NOS)30, the enzyme responsible for NO 
production, in a mouse model of type 2 diabetes. It has been reported that GIP favors 
bone formation in vivo, which seems contradictory to our in vitro observations, since NO is 
essential for bone formation while we found a reduction in NO production in cells treated 
with GIP compared to cells treated without GIP. However, the concentration of GIP in the 
serum during fasting is 0.06 nM and after food ingestion 0.2 nM31. It might thus be more 
justified to compare PFF-stimulated NO production in the presence of 0.05 nM GIP to 0.2 
nM or 0.5 nM GIP, in which case GIP shows a trend towards increasing the magnitude of 
the NO response to PFF (Fig. 2B). In addition, there are multiple other signaling molecules 
important for bone formation, e.g. Sost, PGE
2
, VEGF, and BMP7. These molecules were not 
tested in this study, but they might have been affected by GIP as well. Our results show that 
a mechanical loading regime by PFF significantly decreased the NO production by MC3T3-E1 
osteoblasts after GIP treatment. 
We have used the MC3T3-E1 osteoblast-like cell line as a model to study whether GIP 
affects the response of bone cells to mechanical loading. The MC3T3-E1 cell line is well 
known for its mechano-sensitive properties32,33. We showed that MC3T3-E1 osteoblasts 
respond to PFF with increased NO production. The available MLO-Y4 osteocyte cell line 
needs to be grown in a-MEM, supplemented with 2.5% FBS and 2.5% calf serum. We were 
interested in the effects of a known concentration of GIP on the mechanoresponse of bone 
cells. Since basal GIP serum concentrations vary from 0.06 – 0.1 nm and reach 0.2–0.5 nm 
after food ingestion21,34, we used BSA in the culture medium. The MC3T3-E1 osteoblasts 
adapt well to BSA in the culture medium, while MLO-Y4 osteocytes undergo apoptosis.
We showed that MC3T3-E1 osteoblasts respond to PFF. In addition, the applied 
mechanical stimulus (0.7 ± 0.3 Pa at 5 Hz) during the PFF regime was based on known 
physiologic bone-loading stimuli. Frequency spectra after hip loading in vivo in humans have 
been calculated34, and range from 3 Hz (walking) to 9 Hz (running). The loading-induced 
fluid shear stress in vivo has been predicted to range from 0.8 to 3 Pa28. Bone cells in vitro 
are highly sensitive to shear stress of this order of magnitude, indicating a physiological 
response of these cells.
We found an inhibiting effect of GIP on the PFF-stimulated NO-production by MC3T3-E1 
osteoblasts in vitro. Inhibition of NO production potentiates osteoclastic bone resorption 
in vitro36, and high NO levels have been shown to be important for the prevention of 
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osteoclast recruitment and bone resorption37. However this study does not reveal whether 
NO production is the only parameter affected by GIP treatment, and therefore the effects of 
GIP in vitro on PFF-induced NO-production are not necessarily indicating a negative effect 
on bone mass in vivo. 
In summary, our results show an effect of GIP on the PFF-stimulated NO-production of 
osteoblasts, suggesting an alterated mechano-response. A changed mechano-responsiveness 
in vivo may lead to a change in the balance between osteoblast and osteoclast activity, 
therefore affecting bone mass. We therefore conclude that biological pathways affecting GIP 
might be of interest as new potential targets in the treatment of bone diseases.
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GENERAL DISCUSSION
In this thesis we have identified 1,25(OH)
2
D
3
, sodium fluoride and oleuropein and GIP, 
to have an effect on the NO response of bone cells to mechanical loading. These results 
could contribute to a better understanding of osteoporosis. Skeletal abnormalities such as 
osteoporosis can be seen as the failure of the skeleton to maintain a proper bone mass and 
structure to withstand fracture upon mechanical loading1. Osteoporosis is primarily present 
in the elderly. Since populations age globally, it is to be expected that the incidence of 
osteoporosis-related fractures will rise substantially over the coming decades2. For Europe 
in 2000, there were an estimated 4 million fractures3. The costs of these fractures were 
estimated at € 31.7 billion, and are expected to increase up to € 76.7 billion in 20504. In addition, 
osteoporosis-related fractures lead to diminished quality of life, disability, discomfort and 
death. Thus, prevention of these fractures is urgently required5, and new therapeutic agents 
have been developed6 for that purpose. For example denosumab, a fully human monoclonal 
antibody against receptor activator of nuclear factor κB ligand (RANKL), which regulates 
osteoclast differentiation, activity, and survival, is produced by osteocytes. Denosumab 
inhibits bone resorption and is approved for the treatment of women with postmenopausal 
osteoporosis7. Other examples of anti-osteoporosis drugs are antibodies against sclerostin 
and inhibitors of cathepsin K. In the absence of mechanical stimuli, osteocytes produce 
sclerostin, which inhibits osteoblastic bone formation8. The osteo-anabolic properties of 
monoclonal antibodies to sclerostin, such as AMG 785, have the potential to improve clinical 
outcomes in patients with osteoporosis9. The increasing number of osteoporosis patients, 
bringing along consequences concerning both the individual patient and society, asks for 
intervention. Since the current treatments have drawbacks, such as the inhibition of bone 
formation and the incidental occurrence of osteonecrosis, there is a cry for new therapeutic 
approaches. These new approaches might be found in the prevention of the development 
of osteoporosis, and it is to be expected that a ‘change in lifestyle’, in the form of a well 
balanced diet and daily exercise will contribute to the prevention of osteoporosis.
Physical activity, diet and bone health 
Physical activity and diet are among the most commonly advocated lifestyle measures 
to improve skeletal health10, and are supported by the European Food Safety Authority 
(EFSA). Nutrients like vitamin D and calcium have been recognized to have a beneficial 
effect on bone health for numerous years (EFSA, Panel on Dietetic Products, Nutrition and 
Allergies, 2010), but only recently other nutrients such as vitamin K and B vitamins have 
been fully recognized to contribute to bone health11. With regard to the contribution of 
physical activity, whereby the skeleton is exposed to mechanical loading, Wilhelm Roux 
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(1850-1924) proposed a concept of bone structure adapting to the mechanical demands, 
thereby optimizing the load-bearing function of the skeleton12. Today there is compelling 
evidence that high physical activity positively affects the skeleton by increasing the bone 
mineral content (BMC) and the bone mineral density (BMD)13. A striking example is found in 
athletes, where high load activities during training result in a 10–20% higher BMD compared 
to control subjects14, and a 10–20% gain in BMC15,16. This increased BMC was not found 
in unloaded bones in the same athletes17,18. Moderate physical activity also contributes to 
skeletal health during human skeletal growth19-21. Bone mass at age 70 largely depends on 
peak bone mass22. Peak bone mass is reached between the age of 20 to 30 years23. Therefore 
physical activity during growth could be used as intervention against osteoporosis and/or 
fractures at later age24. Especially in the pre-pubertal and early peri-pubertal years, physical 
activity stimulates rapid bone apposition at bone surfaces25,26, but this effect subsides after 
puberty27,28.
It is known that the combination of frequent mechanical stimuli and nutrition affect 
the skeleton. Several interrelated conditions prevalent in athletes; A strict diet or even 
eating disorder, in combination with decreased endogenous estrogen, can finally result in 
a decrease in bone mass29. In athletes a delayed menarche is not rare, resulting in higher 
risk of failure to reach peak bone mass30. Despite the common eating disorder or at least 
the poor diet, and the disturbed hormonal balance, the total body mineral density/bone 
mineral content ratio of calcified matrix in female athletes was shown to be relatively high31. 
Thus somehow the negative factors caused by poor diet can be counteracted with high 
levels of physical activity. 
Regardless the importance of diet and physical activity for bone, not much is known 
about which specific nutrients contribute to a gain in bone mass, and in which cellular 
pathways the mechanisms that are involved in nutrition and mechanical loading do overlap 
or interact. In this thesis we focused on the effects of nutrients on osteocytes, which are 
the mechanosensitive bone cells that regulate the activity of the bone forming osteoblasts 
and the bone resorbing osteoclasts, in response to mechanical signals. In theory, any factor 
(such as nutrients) that affects the response of osteocytes to mechanical loading will affect 
bone mass. 
Mechanotransduction and bone remodeling
Bone is often thought of as a dead tissue, but the opposite is true. Bone is a combination 
of organic and an-organic matrix, which contains many living cells; osteoblasts, osteoclasts, 
osteocytes, and bone lining cells. Osteoblasts are the bone forming cells. They produce 
collagens32 and non-collagenous proteins, and probably play a role in the initiation of 
calcification of the bone matrix. Osteoclasts demineralize the bone matrix and degrade the 
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collagen33. Together osteoblasts and osteoclasts repair micro damage caused by fatigue 
loading through targeted remodeling, a process believed to be orchestrated by osteocytes34-36. 
This process of bone remodeling leads to adaptation of bone to its mechanical demands 37,38. 
Osteocytes are the bone mechanosensor cells and constitute 95% of all cells in bone. 
During bone formation, a subpopulation of osteoblasts undergoes terminal differentiation 
and become embedded within the bone39. By this time they are referred to as osteoid-
osteocytes40. After mineralization of the bone matrix the entombed cells are called osteocytes. 
Osteocytes form an interconnected cellular network extending throughout the mineralized 
bone. Osteocytes are in contact with neighboring osteocytes via extended cell protrusions 
that make cell-cell contact possible41. The protrusions are positioned within the canaliculi in 
the calcified bone matrix, and they are surrounded by interstitial fluid42. It has been a matter 
of debate how mechanical loading by physical activity of intact bone is transduced into a 
signal that activates the osteocytes43. In the canalicular flow hypothesis by Pieckarski and 
Munro (1977)44 it was proposed that the loads result in deformation within the bone matrix, 
thereby causing a flow of the interstitial fluid through the canalicular network42,44, causing a 
shear stress on the osteocyte protrusions42. Osteocytes can be stimulated by relatively small 
fluid shear stresses acting on the membranes of their osteocytic processes. As a result of 
the shear stress, the glycocalyx shifts and activates kinases. In addition, fluid flow may cause 
a strain amplification in the osteocyte processes45 or open stretch activated ion channels in 
the cell membrane46. The activation of kinases leads to the production of chemical signals. 
As a result of shear stress, osteocytes translate the physical signal into a biochemical signal. 
This process is called ‘mechano transduction’. Subsequently osteocytes produce signaling 
molecules that modulate the activity of osteoblasts and osteoclasts.
Signalling molecules 
Bone Morphogenetic proteins (BMPs) are key proteins in the regulation of cell-cell 
communication and differentiation47,48. Although BMPs are one of the most studied growth 
factors in bone regeneration47, the role of BMPs in bone mechanotransduction had to be 
elucidated. In chapter 2, we show that a mechanical stimulus in the form of a pulsating 
fluid flow, significantly increases BMP7 gene and protein expression in human osteocytes. 
We found that in osteocytes basal BMP2 protein levels were significantly higher than 
basal BMP7 protein levels, but basal BMP2 protein levels were not altered in response to 
mechanical loading. BMP7 is specifically upregulated during mechanical loading induced 
bone remodeling. Since BMP7 is known to play a relevant role in pre-osteoblast maturation 
in bone49, it seems logical that BMP7 is produced to promote pre-osteoblast growth and 
differentiation during mechanical stimulation. The upregulation of BMP7 as a result of a 
mechanical stimulus shown in chapter 2 thus indicates that osteocytes might control 
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osteoblastogenesis via loading induced-BMP7 production. This shows a novel role for BMP7 
in the adaptation of bone to a mechanical stimulus. The upregulation of BMP7 in osteocytes 
by mechanical stimulation was likely mediated by the nuclear vitamin D receptor. Not much 
is known about the function of the vitamin D receptor in the pathways involved in mechanical 
loading. We went more in to the details of this receptor and its role in mechanical loading 
in chapter 3.
Another important early mediator of the response of osteocytes to mechanical 
loading is nitric oxide (NO), released by nitric oxide synthase (NOS), which mediates the 
induction of bone formation by mechanical loading in vivo50,51. In chapter 3 we show that 
1,25-dihydroxyvitamin D
3
 (1,25(OH)
2
D
3
) stimulated NO production by MC3T3-E1 osteoblasts 
but abolished the effect of this mechanical stimulation on NO production, even in cells 
lacking the nuclear VDR. Therefore we suggested that it is likely the membrane VDR receptor 
that is involved in the modulation of NO after incubation with 1,25(OH)
2
D
3
. The VDR is a 
member of a nuclear receptor subfamily which forms heterodimers with RXR and contains 
an AF-2 domain that undergoes ligand-induced conformational change. The regulation of 
gene expression by VDR is dependent of vitamin D responsive elements (VDREs) in the 
promoters of target genes. However, some vitamin D-regulated genes do not contain VDREs 
in their promoters and are thought to be under indirect regulation. Thus it seems that 
vitamin D/VDR affects gene expression by binding to VDREs, but also via regulation of other 
pathways52. One such pathway that is clearly regulated this way by nuclear receptors is the 
wnt pathway, which affects gene expression through β-catenin. Beta-catenin, is required for
cell-cell adhesion and for regulation of gene expression in response to wnt signaling53-55. 
Specific residues in the AF-2 domain of the VDR can discriminate between its classical 
activity and its ability to interact with β-catenin52. Santos et al (2010) showed that PFF 
induces β-catenin stabilization and activation of the β-catenin signaling pathway mediated 
by amongst others NO, in osteocytes56. The role of the 1,25(OH)
2
D
3 
and the VDR in the bone 
cell response to mechanical loading may interact with the Wnt/β-catenin pathway, but 
further research is needed.
The role of the cytoskeleton in mechanical sensing
Lately more evidence emphasizes the role of the cytoskeleton as a structure that is highly 
responsive to external physical and chemical stimuli57. The cytoskeleton is involved in 
mechanosensing and determines the material properties of the cell (i.e., cell stiffness). 
The effects of mechanical stress to an object largely depends on the material properties of 
that object. In bone, low magnitude (<10 με) and high frequency (10–100 Hz) loading can 
stimulate bone mass and strength while high loading rates increase bone mass and strength 
in vivo58. The production of signaling molecules by osteocytes in response to a fluid shear 
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stress (at 5 and 9 Hz) in vitro is correlated with the applied force stimulation59-61. Moreover 
osteocytes with round suspended morphology required lower force stimulation in order to 
show an increase in NO production, even though they were an order-of-magnitude more 
elastic, compared to flat adherent cells62. Apparently elastic osteocytes seem to require less 
mechanical force in order to respond than stiffer cells. This data indicates that differences 
in mechanosensitivity in osteocytes are related to the shape and material properties of the 
cell62. 
Fluoride and oleuropein both affect the cytoskeleton. Fluoride disrupts the cytoskeleton 
of protozoa63, and F-actin in ameloblasts64. Oleuropein is known to induce cell rounding 
in different cell lines in vitro and in mice tumor cells in vivo. The effect of oleuropein on 
tumor cells was explained by an immediate effect of oleuropein on the actin cytoskeleton65. 
In chapter 4 and 5 we discuss the effect of fluoride and oleuropein on the response of 
osteocytes to mechanical stimulation. Having demonstrated that only fluoride has an effect 
on the amount of F-actin fibers and alignment of the fibers, we concluded that fluoride 
treatment results in changed osteocyte shape and mechanical loading-properties. We 
did not find the expected effect of oleuropein on the f-actin cytoskeleton of osteocytes, 
as has been described by others65. It has been reported that oleuropein rounded both 
normal and tumor cells, but the normal cell rounding was reversible after washing. Since 
in our experimental setup cells are not continuously exposed to oleuropein, this might be a 
plausible explanation for the absence of disruption of the cytoskeleton.
The effects of gut hormones on bone health
Upon food intake, the hormone Glucose-dependent insulinotropic polypeptide (GIP) is 
secreted from the intestinal K-cells, which has established insulin-releasing actions. However, 
the GIP receptor (GIPR) is widely distributed in peripheral organs, including bone tissue66. As 
GIPR is found on osteoblasts and osteoclasts, a physiological role for this hormone in bone 
remodelling has been suggested. GIP seems to increase bone density and exerts anabolic 
effect on bone in vitro: in osteoblastic cell lines, GIP dose-dependently prevents apoptosis 
and increases intracellular calcium levels, alkaline phosphatase activity and collagen type 
1 mRNA levels67. Furthermore, postprandial activation of osteoclast GIPR inhibits bone 
resorption68. After meal ingestion, GIPR-knock-out mice had increased plasma calcium 
levels compared to wild-type animals. In addition, bone resorption markers decreased after 
oral and intravenous administration of nutrients in presence of GIP, suggesting GIP directly 
stimulates calcium uptake and bone formation by osteoblasts postprandially68. Lately 
evidence rises suggesting exercise may acutely modulate GIP action in humans69. In chapter 
6 we describe the effect of GIP treatment on the mechanosensitivity of bone cells. We 
found that 2 h incubation with GIP increased osteoblast NO production upon mechanical 
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stimulation, suggesting that there might be a connection between exercise, activation of GIP 
action and the response of bone cells to this mechanical stimulus.
The ability of nutrients to affect the mechano-response of bone cells
The classic role of the vitamin D endocrine system is to stimulate calcium absorption in 
the intestine, thus maintaining normal calcium homeostasis and indirectly regulating bone 
mineralization70. 1,25(OH)
2
D
3
 induces the differentiation of osteoblasts via sequential 
induction of cell cycle arrest71, maturation of extracellular matrix and finally bone 
mineralization72. Rickets and osteomalacia are the diseases traditionally associated with 
severe vitamin D deficiency, defined as 25-hydroxyvitamin D levels below 25 nmol/l. Less 
severe degrees of vitamin D deficiency (25 and 50 nmol/l) and vitamin D insufficiency, (50 and 
75 nmol/l), already impair gastrointestinal absorption of calcium and bone mineralization, 
contributing to the pathogenesis of osteoporosis in older people73. The importance of vitamin 
D for bone health and the prevention of osteomalacia and osteoporosis are well recognized. 
In a rat model of hind limb unloading, exogenous 1,25(OH)
2
D
3
 not only prevented the bone 
loss but also increased the bone mineral density to greater than the baseline level (+7%). 
These results suggest that elevating circulating 1,25(OH)
2
D
3
 levels presumably increasing 
calcium absorption can counteract bone loss induced by disuse or microgravity with its 
associated reductions in circulating 1,25(OH)
2
D
3
 and decreased calcium absorption74. Our 
mechanical loading studies did show an effect of 1,25(OH)
2
D
3 
on the mechanosensitivity of 
osteoblasts, in terms of NO production.
The fluoride anion substitutes hydroxyl in hydroxyl-apatite crystals, thereby changing the 
crystalline structure of bone tissue75. Fluoridated hydroxyl-apatite increases osteoblast cell 
attachment, proliferation and differentiation76. Fluoride also stimulates bone formation at 
cellular77,78, tissue79 and organ levels80, leading to an increase in trabecular bone volume79,81 
in osteoporotic patients. Fluoride therapy on the osteopenic bone of the ovariectomized rat 
causes an increase of bone stiffness due to the presence of fluoroapatite. This introduces 
new properties in osteopenic rat bone: higher resistance to compression loading and a 
greater frailty to flexion loading82. In another study, the effect of increasing fluoride doses on 
the bone formation, microarchitecture, mineralization and microhardness of the A/J, SWR/J 
and 129P3/J mouse strains was assessed. Fluoride treatment had no significant effect on 
bone microarchitecture in these three strains83. In our study, we found that fluoride had an 
effect on NO production of mechanically stimulated osteocytes, and cellular f-actin content. 
We concluded that, based on these findings, fluoride might changes the biomechanical 
properties of the cell via changes in f-actin content, and thereby the response to mechanical 
stimuli. In vivo this would result in more brittle bone, caused by less mechanosensitive bone 
cells.
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To the best of our knowledge, it is unknown whether oleuropein has the ability to alter 
the mechanical properties of bone cells. However few studies have shown that oleuropein 
alters the actin cytoskeleton63,64. Earlier we explained that the cytoskeleton is a major 
component in determining the mechanical response of the cells62. We found that oleuropein 
itself did not alter the mechanoresponse of osteocytes, nor did it alter the cellular f-actin 
content. Therefore the effect of oleuropein on COX-2 gene expression is not mediated via 
the cytoskeleton. 
Conclusion
The increasing number of osteoporosis patients is accompanied with high costs and 
decreased quality of life. This asks for a new therapeutic approach in the near future. 
These approaches preferably need to be found in the prevention of the development of 
osteoporosis, and should be non-invasive. Suggested is a ‘change in lifestyle’, daily exercise 
and a balanced diet, possibly fortified with bone formation stimulating nutrients. Therefore 
it will be necessary to determine which nutrients enhance bone mass, amongst others 
via an increase in the sensitivity of bone cells to mechanical stimuli. In this thesis we have 
identified 1,25(OH)
2
D
3
, sodium fluoride to have an effect on the response of bone cells to 
mechanical loading. However, the found effects had no extra effect on the amount of NO 
produced by osteocytes on top of the NO production in response to mechanical loading 
alone. Although conditions such as vitamin D toxicity and fluorosis are rare, they do occur at 
excessively high doses, and result into hypercalcemia and hyperphosphatemia84, excessive 
osteoid formation and incomplete mineralisation85,86 Intoxication can be iatrogenic, due 
to self medication or accidental with abuse of fortified milk product or contamination of 
common dietary constituents like table sugar or cooking oil. Therefore we recommend daily 
exercise and a balanced diet. Consumption of foods such as vitamin enriched milk products 
might be beneficial when the natural intake is not sufficient, but should not be needed when 
the diet is well balanced.
A better understanding of the pathways involved in mechano-transduction and regulating 
factors in daily nutrition are necessary to develop such strategies.The results described in 
this thesis contribute to a better understanding of interactions between bone, daily loading 
and diet, which might be of importance for the development of new strategies to prevent 
osteoporosis. 
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Bones adapt their mass and structure to the demands of mechanical usage in order to 
achieve an optimal resistance to mechanical failure with a minimum use of material. This 
process is known as functional adaptation of bone and occurs during bone remodeling. In 
the process of bone remodeling, osteoclasts resorb the bone, while osteoblasts deposit 
new bone. This interplay between osteoclasts and osteoblasts is tightly coordinated by 
the mechanosensing osteocytes. When osteocytes are mechanically loaded, they start 
to produce signaling molecules, such as nitric oxide (NO), that affects bone formation. In 
addition to mechanical loading, several nutrients are also able to affect NO production, but 
the combined effect of mechanical usage and nutrients on the production of NO by bone 
cells has not been elucidated. 
This thesis focuses on the effect of nutrients on the response of mechano-sensitive bone 
cells to mechanical stimuli. The aim was to identify nutritional factors that alter the bone 
cell response to mechanical loading. We also assessed whether the combination of certain 
nutrients and mechanical stimuli can counteract the effects of inflammatory cytokines 
on mechanosensitive bone cells, since bone loss associated with systemic inflammatory 
diseases may involve elevated cytokines levels.
In this thesis the following scientific questions were addressed:
1. What are the pathways leading to the release of signaling molecules, specifically bone 
morphogenetic proteins, by bone cells in response to mechanical loading?
2. How do dietary components that are used as agents in osteoporosis treatment, such 
as 1,25-dihydroxyvitamin D
3
 and fluoride, affect the response of osteocytes to mechanical 
stimulation? 
3. Could nutrients such as oleuropein potentially counteract inflammation-induced bone 
loss by restoring the altered response of bone cells to mechanical stimuli in an environment 
of inflammation?
To seek answers to these questions we first assessed whether osteocytes produce BMPs 
in response to mechanical loading (Chapter 3). We demonstrated that mechanical loading 
by pulsating fluid flow (PFF) upregulates BMP7 gene and protein expression in osteocytes 
in vitro, likely via the vitamin D receptor (VDR). BMP2 gene and protein expression was not 
affected by PFF. 
1,25-dihydroxyvitamin D
3 
(1,25(OH)
2
D
3
) mediates bone mass. The genomic responses to 
1,25(OH)
2
D
3
 are mediated by the vitamin D receptor (VDR), a steroid hormone nuclear 
receptor. In addition, 1,25(OH)
2
D
3
 seems to mediate cellular responses via a variety of 
receptor types located within or near the plasma membrane. In chapter 4 we aimed to 
determine whether 1,25(OH)
2
D
3 
affects the production of NO by osteoblasts that are 
either or not mechanically stimulated by PFF. We expected 1,25(OH)
2
D
3
 to stimulate NO 
production by osteoblasts via the VDR, rather than via rapid membrane receptor-mediated 
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mechanisms. We showed that 1,25(OH)
2
D
3 
stimulates inducible NOS expression and NO 
production by osteoblasts in the absence of mechanical stimulation, likely via genomic 
VDR action. However the mechanical loading-induced NO production might be affected by 
1,25(OH)
2
D
3
 independent of genomic VDR action, since 1,25(OH)
2
D
3
 diminished PFF-induced 
NO production in bone cells lacking the VDR.
The bone anabolic agent fluoride has been used for decades to enhance bone mass 
in osteoporosis, but it is known to disrupt the cytoskeleton. Since the response of bone 
cells to mechanical loading is mediated by the cytoskeleton, we investigated whether 
fluoride affects the response of bone cells to mechanical loading by PFF, and whether 
this is cytoskeleton-mediated. Fluoride inhibited the mechanical loading-stimulated NO 
production, and decreased the amount of the cytoskeletal component F-actin. Treatment of 
young hamsterds with fluoride resulted in more elongated, smaller osteocytes in interdental 
bone (Chapter 5). This suggests that fluoride inhibits the mechano-response of bone cells, 
which might occur via cytoskeletal changes.
The inflammatory cytokine interleukin-1b (IL-1b) reduces the response of osteocytes 
to mechanical stimuli. Phenolic dietary compounds counteract the effects of inflammatory 
cytokines. We showed that the phenolic compound oleuropein affects the response of IL-
1b–treated osteocytes to mechanical stimulation by PFF. We also found that the NO response 
to mechanical loading was lower in human osteoblasts from osteoporotic patients than in 
control bone cells. In MLO-Y4 osteocytes, IL-1β reduced mechanical loading-stimulated NO 
production, which could not be reversed by oleuropein treatment. IL-1b also decreased 
F-actin content and COX-2 gene expression in response to mechanical loading Oleuropein 
prevented the effect on COX-2 expression, but not on F-actin content. Our results suggest 
that oleuropein may reduce the inflammation-induced bone loss in vivo by reducing the 
inhibitory effect of IL-1b on PFF-stimulated COX-2 gene expression (Chapter 6).
Glucose-dependent insulinotropic peptide (GIP) is a gut-hormone that is released by 
entero-endocrine K-cells in the duodenum and jejunum in response to carbohydrate and 
fat ingestion. GIP is known to have an effect on bone mass and bone micro-architecture, 
but its mechanism of action is unclear. In view of GIP’s role in nutrient absorption, it might 
play a role in linking nutrient ingestion to bone formation. We aimed to determine whether 
GIP modulates the response of mechanosensitive osteoblasts to mechanical stimulation. 
Treatment with GIP decreased the mechanical loading-stimulated NO production by 
osteoblasts suggesting that GIP affects the mechano-response of osteoblasts (Chapter 7).
In this thesis we have identified 1,25(OH)
2
D
3
, sodium fluoride, oleuropein and GIP 
to have an effect on the NO response of bone cells to mechanical loading. These results 
could contribute to a better understanding of osteoporosis. The increasing number of 
osteoporosis patients asks for new therapeutic approaches in the near future. These 
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approaches preferably need to be found in the prevention of osteoporosis, and should be 
non-invasive. Daily exercise and a balanced diet, possibly fortified with bone formation 
stimulating nutrients, might be such a new approach. Therefore a better understanding of 
the pathways involved in mechano-transduction and regulating factors in daily nutrition are 
necessary to develop such strategies. The results described in this thesis contribute to a 
better understanding of interactions between bone, daily loading and diet, which might be 
of importance for the development of new strategies to prevent osteoporosis. 
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Botten adapteren hun massa en structuur aan de eisen van de mechanische belasting om 
een optimale weerstand tegen mechanisch falen te bereiken met een minimale benutting 
van materiaal. Dit proces staat bekend als functionele adaptatie van bot en vindt plaats 
tijdens bot-remodellering. Tijdens het proces van bot-remodellering wordt het bot door 
osteoclasten geresorbeerd, terwijl osteoblasten nieuw bot aanmaken. Dit samenspel tussen 
osteoclasten en osteoblasten wordt strikt gecoördineerd door de drukgevoelige osteocyten. 
Wanneer osteocyten mechanisch belast worden gaan ze signaal moleculen produceren, 
zoals stikstofoxide (NO), dat de botvorming beïnvloedt. Zowel mechanische belasting als 
ook verscheidene voedingsstoffen kunnen de NO productie beïnvloeden, maar het effect 
van een combinatie van mechanische belasting en voedingsstoffen op de NO productie is 
nog onbekend.  
Dit proefschrift richt zich op het effect van voedingsstoffen op de reactie van drukgevoelige 
botcellen op mechanische belasting. Het doel was om voedingsstoffen te identificeren die een 
verandering in de reactie van botcellen op mechanische belasting kunnen bewerkstelligen. 
We hebben ook onderzocht of de combinatie van bepaalde voedingsstoffen en mechanische 
belasting het negatieve effect van ontstekingsmediatoren op botcellen kan opheffen, omdat 
verhoogde concentraties van ontstekingsmediatoren mogelijk een rol spelen bij het bij 
botverlies geassocieerd met systemische ontstekingsziekten. 
In dit proefschrift werden de volgende wetenschappelijke vragen aan de orde gesteld:
1.  Welke biochemische routes leiden tot de afgifte van signaalmoleculen, in het bijzonder 
“bone morphogenetic proteins”, door botcellen in reactie op mechanische belasting?
2.  Hoe beïnvloeden voedingscomponentenin het dieet die worden gebruikt ter behandeling 
van osteoporose, zoals 1,25-dihydroxyvitamin D
3
 en fluoride, de reactie van osteocyten 
op mechanische belasting?
3.  Hebben voedingsstoffen zoals oleuropeïne de potentie om botverlies veroorzaakt 
door ontstekingsreacties tegen te gaan door de veranderde reactie van botcellen op 
mechanische belasting bij ontsteking te herstellen.
Om deze vragen te beantwoorden hebben we eerst bepaald of osteocyten in reactie 
op mechanische belasting BMPs produceren (Hoofdstuk 3). We hebben aangetoond dat 
mechanische belasting in de vorm van een pulserende vloeistofstroom (“pulsating fluid flow” 
(PFF)), de gen- en eiwitexpressie van BMP7 in osteocyten in vitro verhoogd, vermoedelijk via 
de vitamine D receptor (VDR). PFF had geen effect op de gen- en eiwitexpressie van BMP2.
1,25-dihydroxyvitamin D
3 
(1,25(OH)
2
D
3
) medieert de botmassa. De genomische reacties 
op 1,25(OH)
2
D
3
 worden gemedieerd door de VDR, een steroïd hormoon kernreceptor. 
1,25(OH)
2
D
3
 kan waarschijnlijk ook cellulaire reacties bewerkstelligen via een aantal 
receptoren die gelegen zijn in of tegen het plasmamembraan. In hoofdstuk 4 was het doel 
om aan te tonen dat 1,25(OH)
2
D
3 
een effect heeft op de productie van NO door osteoblasten, 
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die al dan niet mechanisch belast werden met PFF. Wij verwachtten dat 1,25(OH)
2
D
3
 de NO 
productie door osteoblasten zou stimuleren via the VDR maar niet via de snelle membraan 
receptor-gemedieerde mechanismen. We hebben aangetoond dat in de afwezigheid van 
mechanische belasting 1,25(OH)
2
D
3 
de expressie van “inducible NOS” en de productie van 
NO door osteoblasten stimuleert, waarschijnlijk via de kernreceptor. Het is echter ook 
mogelijk dat de door mechanische belasting-geïnduceerde NO productie onafhankelijk 
van de VDR kernreceptor wordt beïnvloedt door 1,25(OH)
2
D
3
, , omdat 1,25(OH)
2
D
3
 de PFF-
geïnduceerde NO productie door botcellen zonder deze VDR verminderde.
Het voor bot anabole agens fluoride is decennia lang gebruikt om de vorming van 
botmassa in osteoporose patiënten te stimuleren, maar van fluoride is het ook bekend dat 
het het cytoskelet verbreekt. Omdat de reactie van botcellen op mechanische belasting 
wordt gemedieerd door het cytoskelet, hebben wij onderzocht of fluoride de reactie van 
botcellen op mechanische belasting door PFF beïnvloedt, en of dit cytoskelet gemedieerd 
is. Fluoride inhibeerde de door mechanische belasting gestimuleerde NO productie, en 
verlaagde de hoeveelheid F-actine, een bestanddeel van het cytoskelet. In jonge hamsters 
die met fluoride waren behandeld waren de osteocyten in interdentaal bot langer en kleiner 
(Hoofdstuk 5). Dit suggereert dat fluoride de reactie van botcellen op mechanische belasting 
inhibeert, vermoedelijk door veranderingen in het cytoskelet. 
Het inflammatoire cytokine interleukine-1b (IL-1b) verlaagt de reactie van osteocyten op 
mechanische belasting. In de voeding aanwezige fenolen kunnen de effecten van cytokines 
tegenwerken. Wij hebben aangetoond dat het fenol oleuropeïne de reactie van IL-1b 
behandelde osteocyten op mechanische belasting door PFF verandert. Ook hebben we 
gevonden dat de NO respons op mechanische belasting lager was in humane osteoblasten 
van osteoporose patiënten dan in controle botcellen. In MLO-Y4 osteocyten verminderde 
IL-1β de mechanische belasting-gestimuleerde NO productie, die niet worden hersteld 
door toevoeging van oleuropeïne. IL-1b verlaagde ook de hoeveelheid F-actine en COX-2 
genexpressie in respons op mechanische belasting. Toevoeging van oleuropeïne voorkwam 
het effect op COX-2 genexpressie, maar niet op de hoeveelheid F-actine. Onze resultaten 
suggereren dat oleuropeïne het ontstekings-gemedieerde botverlies in vivo vermindert 
door het effect van IL-1b op de PFF-gestimuleerde COX-2 genexpressie te verminderen 
(Hoofdstuk 6).
Glucose-afhankelijk insulinotropisch polypeptide (GIP) is een darm-hormoon dat wordt 
afgegeven door entero-endocriene K-cellen in de twaalf-vingerige darm en de dunne 
darm na inname van koolhydraten of vet. Van GIP is bekend dat het een effect heeft op 
de botmassa en op de bot micro-architectuur, maar het werkingsmechanisme van GIP is 
onduidelijk. Met het oog op de rol van GIP bij de opname van voedingsstoffen zou het een 
wellicht een rol kunnen spelen bij de link tussen opname van voedingsstoffen en botvorming. 
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Ons doel was om te onderzoeken of GIP de reactie van mechanogevoelige osteoblasten 
op mechanische stimulatie beïnvloedt. Behandeling met GIP verlaagde de mechanische 
belasting-gestimuleerde NO productie door osteoblasten, hetgeen suggereert dat GIP de 
mechano-respons van osteoblasten beïnvloedt (Hoofdstuk 7).
In dit proefschrift hebben we aangetoond dat 1,25(OH)
2
D
3
, fluoride, oleuropeïne en GIP 
een effect hebben op de NO productie door botcellen in respons op mechanische belasting. 
Deze resultaten kunnen bijdragen aan een beter begrip van osteoporose. Het stijgende 
aantal osteoporose patiënten vraagt om een nieuwe therapeutische aanpak in de nabije 
toekomst. Deze aanpak zal bij voorkeur gezocht moeten in de preventie van osteoporose 
en moet niet-invasief zijn. Dagelijkse beweging en een uitgebalanceerd dieet, waar mogelijk 
verrijkt met specifieke voedingsstoffen die de botvorming stimuleren, is zo’n mogelijke 
aanpak. Om nieuwe strategieën te ontwikkelen is meer kennis nodig van de biochemische 
routes die betrokken zijn bij de mechano-transductie, en van de regulerende factoren in het 
dagelijks dieet. De resultaten beschreven in dit proefschrift dragen bij aan een beter begrip 
van de interacties tussen bot, dagelijkse belasting en dieet, hetgeen van belang kan zijn voor 
de ontwikkeling van nieuwe strategieën ter voorkoming van osteoporose. 
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In den beginne, de eerste week, was promoveren spannend. Totdat bleek dat er die week 
niemand was om het project mee door te nemen, te brainstormen. Ik werd geplaatst in 
het kantoor van Astrid, die zelf op een super spannende vakantie was in Jordanië. Met 
wat oude proefschriften en toegang tot het wereld wijde web, werd ik geacht mijzelf in te 
lezen. Het onderzoeksvoorstel had ik niet, maar wel wat oude proefschriften. Ik heb mijzelf 
daar maar op gestort, en gelukkig was het toen bijna tien uur. De deur vloog open en een 
super enthousiaste Jolanda stormde binnen en vertelde dat bij OCB elke ochtend om 10.00 
de koffie klaar stond. En op dat moment voelde ik mij dus zeer welkom. In de weken die 
volgden leerde ik langzaam aan iedereen kennen, en de meeste nieuwe mensen waren zeer 
vriendelijk en behulpzaam. Later die week was ook mijn eerste meeting met Jenneke, mijn 
waarde promotor. En vele meetings volgden. En deze meetings waren stuk voor stuk zeer 
bijzonder. Jenneke heeft mij in de afgelopen 5 jaar getracht veel dingen bij te brengen. Hoe 
dingen ‘moeten’ en ‘horen’. Want Jenneke weet dat, Jenneke is de professor. En zegt ze er 
vaak geruststellend bij, ’jij kan dat ook niet weten, want je bent nog maar AiO’. En ik heb 
veel geleerd. Hoe dingen moeten, maar vooral ook, hoe dingen niet moeten. Presentaties 
werden uitvoerig geoefend, niet zelden tot in de late uurtjes, waarop meer dan eens door 
Jenneke werd gevraagd haar dan toch gewoon maar na te spreken. Maar het resultaat was 
er wel naar. Abstracts, publicaties, presentaties, ze klopten tot in de puntjes. Maar gelukkig 
kon ik ook Jenneke nog wat leren. Met hulp van Nina is ze bekend geworden met de meest 
verkochte cocktails, kent ze nu meer dan 3 smaakjes jenever, weet ze het ‘kleine cool down 
cafe’ blind te vinden en is ze nu een groot fan van Dries Roelvink. Ik kan dan ook alleen maar 
zeggen dat de afgelopen 5 jaar onvergetelijk waren, en dat Jenneke daar voor een groot deel 
verantwoordelijk voor is.
Mijn co-promotor Ellen is een compleet ander verhaal. Ellen werkte in Deventer, en was 
niet vaak in beeld, maar ze was altijd enthousiast, blij met nieuwe resultaten, en was vaak 
de aanzetster van nieuwe ideeën en experimenten. Ondanks de afstand, hield Ellen een 
flinke vinger in de pap. Regelmatig hadden we meetings waarbij Ellen steeds de kant van 
de nutriënten bleef benadrukken. Het was dan ook zeer leerzaam om samen met Ellen de 
review te schrijven. En Ellen hield ons met beide benen op de grond. Wij (van ACTA) hadden 
vaak het idee al klaar te zijn met het manuscript als Ellen nog met input kwam, waardoor 
het werk uiteindelijk naar een ander niveau werd gebracht. Zonder Ellen had dit proefschrift 
dan ook nooit zijn huidige vorm bereikt. 
Astrid werd pas na 2 jaar officieel mijn co-promotor. Het was fijn om met Astrid te bomen 
over experimenten. Meer dan eens heeft ze me uit de wetenschappelijke put getrokken en 
verteld dat ik het allemaal wel kon. Dat was een mooi tegengeluid. Verder hebben we best 
veel lol gehad op NVCB meetings, girls only events, de Dries premiere, en Toronto. Ja, we 
zijn zelfs samen in Toronto geweest. Waar Astrid letterlijk ‘to the rescue’ kwam, en ‘a girls 
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right to have meat balls’ zeer dapper heeft verdedigd. Als ik alle avonturen beleefd met 
Astrid zou opschrijven zou dit een zeer ongeloofwaardig dankwoord worden, en dat is niet 
de bedoeling. Maar Astrid heeft een zeer groot aandeel in het feit dat ik het zover heb 
gebracht, en daarom alleen al is ze goud!
Een ander persoon die de afgelopen 5 jaar steeds weer om de hoek kwam kijken was 
Ruud. Ruud Schoemaker. Vanaf de eerste meeting was Ruud nauw betrokken bij het project. 
En ik was meteen onder de indruk van alle kennis over nutriënten die zich ophield in Ruud’s 
hoofd. En niet alleen over nutriënten weet Ruud veel, je kunt ook nog eens gezellig kletsen 
over niet werk gerelateerde onderwerpen. Een ware verademing! En Ruud herkende zelfs 
psycho Bob in Jenneke’s kantoor! Ruud, dank je wel voor al je hulp de afgelopen jaren!
Voor het schrijven van de verschillende publicaties kwam veelal hulp uit onverwachte 
hoek. De eerste paper die gepubliceerd werd had niet tot stand kunnen komen zonder 
de inbreng en input en wijze woorden van Ton Bronckers. De eerste keer dat ik Ton zag, 
noemde hij mijn NutriBone project het ‘koetjeboe-project’. Gelukkig weerhield dat Ton er 
niet van om mij te helpen met de fluoride paper, en met het idee van de uitbreiding met 
de hamsterkaakjes te komen. En hij zorgde ook nog eens voor 2 studenten die de metingen 
konden doen (ik hoefde hen dan alleen maar te begeleiden). Ton, bedankt voor je hulp en 
je (mee)luisterend oor! De tweede paper over de effecten vitamine D op de NO productie 
van botcellen mede dankzij de hulp van Professor Geert Carmeliet uit Leuven tot stand 
gekomen. Hartelijk dank voor uw wetenschappelijke input en het beschikbaar stellen van 
de muizen. Ook wil ik Ingrid Stockmans bedanken voor het kweken en verzorgen van de 
dieren, en alle hulp die ik kreeg als ik weer naar Leuven kwam. Eerder noemde ik al mijn 
twee studenten, maar de heren hadden ook een naam. Seb Castelein en Joost Keverling-
Buisman. Mijn eerste (en enige) echte studenten. Dank aan jullie beiden voor het werk wat 
jullie hebben verricht aan de metingen in de hamsterkaakjes. Ik hoop dat ik jullie iets heb 
kunnen leren, en jullie de wetenschap niet helemaal de rug zullen toekeren. Jullie eerste 
publicatie is in ieder geval al binnen. En ik heb van jullie geleerd dat je met stroop nog steeds 
meer vliegen vangt dan met azijn, slijmballen!
Nou vraagt u zich misschien af of ik de rest dan wel allemaal alleen heb gedaan. Wat 
denkt u zelf? Natuurlijk niet! De eerste week heb ik constant aan het handje van Jolanda 
en Cor gelopen. Als een jong angstig eendje liep ik de eerste weken over het lab. Bang 
om dingen stuk te maken, bang om de medische faculteit op te blazen, bang voor… Maar 
dankzij Cor en Jolanda kwam alles goed. Cor die mij de beginselen van fluid flow heeft 
bijgebracht, en Jol die mij wegwijs maakte met de lab etiquette (ruim je rommel op, schrijf 
overal duidelijk je naam op, vul iets bij als het op is, taart). Jol, dankjewel voor alle keren 
dat je voor me opkwam, bedankt dat je me uit de brand hebt geholpen met de laatste 
experimenten. Ook bedankt dat je me er regelmatig aan herinnerde dat ik wel ‘een beetje 
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stupide was’, je houdt de AiO’s altijd lekker met beide beentjes op de grond. Maar vooral 
dank voor alle gezelligheid die je OCB brengt! Cor, jij ook bedankt voor alles wat je me op 
het lab hebt geleerd, voor je luisterend oor, en het delen van de Fokke&Sukke kalender, en 
de gezelligheid. Let it snow, let it snow, let it snow! Ook ben ik Dirk-Jan dankbaar voor alle 
vage stofjes die hij voor me besteld heeft, Marion wil ik bedanken voor haar luisterend oor 
en scherpe humor, en Don voor het leveren van de hamsterkaakjes.
Bijzondere dank gaat uit naar mijn paranimf Nina. We hebben samen het AMC overleefd, 
Sanquin onveilig gemaakt, OCB opgeschud, en hoe fantastisch is het dat we de komende 
twee jaar samen met Candida gaan spelen?! Dankzij jou was het nooit saai tijdens de lunch, 
tijdens congressen, presentaties en andere werk gerelateerde dingen die zonder jou als saai 
aangeduid zouden kunnen worden. Ik was supertrots dat ik jouw paranimf mocht zijn, en 
ben heel blij dat je mijn paranimf wilt zijn. Bedankt! Een andere bijzondere vriendin (en 
collega) die de afgelopen jaren net iets gezelliger maakte is Greetje. Samen op congres in 
Wenen (wat was ik blij dat je er was) met als hoogtepunt de high tea bij Haas und Haas. Dank 
je wel dat je er voor mij was, samen met Sas!
Verder wil ik mijn roomies van de afgelopen jaren allemaal bedenken voor hun 
gezelligheid; Aviral, Agnes, dokter Ruud, Janice, Petra, Rishikesh, Eli, Anna en Qi long. Dank 
jullie allemaal voor het delen van AiO lief en leed, smeuige roddels en ranzige verhalen! Maar 
ook Wilco, Hans en Peter bedankt voor de bemoedigende woorden en gezelligheid tijdens 
koffie, borrels en congressen. En natuurlijk baby Mark. Je paste je razendsnel aan en ik zal 
die ene NVCB niet gauw vergeten. Teun, Ineke en Sietske, dank jullie voor de gezelligheid in 
Toronto! Mede dankzij jullie heb ik het er zonder al te veel kleerscheuren vanaf gebracht. Ik 
kan toch ook maar mooi zeggen dat ik met dr de Vries de Niagara falls heb gezien! Verder wil 
ik iedereen bij OCB en functionele anatomie bedanken voor de afgelopen 5 jaar, voor jullie 
gezelligheid en luisterend oor tijdens koffietijd, lunchtijd of borreltijd!
De afgelopen 5 jaar stonden in teken van de promotie, maar de jaren ervoor waren van 
cruciaal belang om daar te komen. Mijn interesse in de biologie werd tenslotte op de mavo 
gewekt dankzij de altijd interessante lessen van meneer Kooij en meneer van Rij. Tijdens 
mijn studie biomedische wetenschappen werd heb ik verschillende stages gedaan, en die 
zijn niet allemaal even prettig verlopen. Toch heeft de minst fijne stage mij de kans gegeven 
een paar van de leukste vriendinnen die ik heb te leren kennen. Ro(mana), we zien elkaar 
niet veel, maar als we afspreken wordt er gelachen, gegeten en geroddeld. De Bananen, 
waarvan ook Nina en Greetje lid zijn, zijn niet compleet zonder Elise, Sarah en Marleen. 
Dank jullie voor jullie luisterend oor, en dank dat jullie er niet alleen voor mij zijn in goede 
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